Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Survival Analysis

FacultyTitle
3A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls. (Khanal M, Logan BR, Banerjee A, Fang X, Ahn KW) Pharm Stat 2025;24(1):e2464    
1Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. (Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS, NIAGARA Investigators) N Engl J Med 2024 Nov 14;391(19):1773-1786       65 Citations
3Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies. (Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M) Br J Haematol 2024 Nov;205(5):1830-1834       3 Citations
1Machine learning identifies prognostic subtypes of the tumor microenvironment of NSCLC. (Yu D, Kane MJ, Koay EJ, Wistuba II, Hobbs BP) Sci Rep 2024 Jul 01;14(1):15004       1 Citation
1Survival differences by race and surgical approach in early-stage operable cervical Cancer. (Summey R, Benoit M, Williams-Brown MY) Gynecol Oncol 2023 Dec;179:63-69       1 Citation
1Dynamic Treatment Regimes Using Bayesian Additive Regression Trees for Censored Outcomes. (Li X, Logan BR, Hossain SMF, Moodie EEM) Lifetime Data Anal 2024 Jan;30(1):181-212       1 Citation
1Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade. (Choby G, Geltzeiler M, Almeida JP, Champagne PO, Chan E, Ciporen J, Chaskes MB, Fernandez-Miranda J, Gardner P, Hwang P, Ji KSY, Kalyvas A, Kong KA, McMillan R, Nayak J, O'Byrne J, Patel C, Patel Z, Peris Celda M, Pinheiro-Neto C, Sanusi O, Snyderman C, Thorp BD, Van Gompel JJ, Young SC, Zenonos G, Zwagerman NT, Wang EW) JAMA Otolaryngol Head Neck Surg 2023 Sep 01;149(9):837-844       18 Citations
1Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. (Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA) Bone Marrow Transplant 2023 Oct;58(10):1089-1095    
1Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers. (Sharma A, Logan B, Estrada-Merly N, Lehmann LE, Rangarajan HG, Preussler JM, Troy JD, Akard LP, Bhatt NS, Truong TH, Wood WA, Strouse C, Juckett M, Khera N, Rizzo D, Saber W) Transplant Cell Ther 2023 Aug;29(8):523-528       2 Citations
1DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. (Dillon LW, Gui G, Page KM, Ravindra N, Wong ZC, Andrew G, Mukherjee D, Zeger SL, El Chaer F, Spellman S, Howard A, Chen K, Auletta J, Devine SM, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Weisdorf DJ, Hourigan CS) JAMA 2023 Mar 07;329(9):745-755       91 Citations
1Deflection-based parametric survival analysis side impact chest injury risk curves AIS 2015. (Humm JR, Banerjee A, Yoganandan N) Traffic Inj Prev 2021;22(sup1):S44-S48       1 Citation
1Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma. (Chakiryan NH, Dahmen A, Bandini M, Pederzoli F, Marandino L, Albersen M, Roussel E, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Briganti A, Salvioni R, Montorsi F, Necchi A, Spiess PE) Urol Oncol 2021 Dec;39(12):838.e7-838.e13       7 Citations
1Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. (Riedell PA, Hamadani M, Ahn KW, Litovich C, Brunstein CG, Cashen AF, Cohen JB, Epperla N, Hill BT, Im A, Inwards DJ, Lister J, McCarty JM, Ravi Kiran Pingali S, Shadman M, Shaughnessy P, Solh M, Stiff PJ, Vose JM, Kharfan-Dabaja MA, Herrera AF, Sauter CS, Smith SM) Br J Haematol 2021 Dec;195(5):757-763       5 Citations
1Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. (Schulte R, Hinson A, Huynh V, Breese EH, Pierro J, Rotz S, Mixon BA, McNeer JL, Burke MJ, Orgel E) Cancer Med 2021 Nov;10(21):7551-7560       15 Citations
2Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes. (Iden M, Tsaih SW, Huang YW, Liu P, Xiao M, Flister MJ, Rader JS) Br J Cancer 2021 Nov;125(10):1408-1419       16 Citations
1Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. (Sokolova AO, Marshall CH, Lozano R, Gulati R, Ledet EM, De Sarkar N, Grivas P, Higano CS, Montgomery B, Nelson PS, Olmos D, Sokolov V, Schweizer MT, Yezefski TA, Yu EY, Paller CJ, Sartor O, Castro E, Antonarakis ES, Cheng HH) Prostate 2021 Dec;81(16):1382-1389       12 Citations
1Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. (Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Cheng TD, Clarke CL, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Dörk T, Dossus L, Dunning AM, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, Gago-Dominguez M, García-Sáenz JA, Giles GG, Grip M, Guénel P, Gündert M, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hart SN, Hartikainen JM, Hartmann A, He W, Hooning MJ, Hoppe R, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab Investigators, Jager A, Jakubowska A, Janni W, John EM, Jung AY, Kaaks R, Keupers M, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lacey JV, Lambrechts D, Le Marchand L, Lindblom A, Linet M, Luben RN, Lubiński J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Martens JWM, Martinez ME, Mavroudis D, Michailidou K, Milne RL, Mulligan AM, Muranen TA, Nevanlinna H, Newman WG, Nielsen SF, Nordestgaard BG, Olshan AF, Olsson H, Orr N, Park-Simon TW, Patel AV, Peissel B, Peterlongo P, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Rack B, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Ruebner M, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott C, Shah M, Smichkoska S, Southey MC, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teras LR, Terry MB, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Vachon CM, Wang Q, Hurson AN, Winqvist R, Wolk A, Ziogas A, Brauch H, García-Closas M, Pharoah PDP, Easton DF, Chenevix-Trench G, Schmidt MK) Breast Cancer Res 2021 Aug 18;23(1):86       11 Citations
2Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. (Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W) Transplant Cell Ther 2021 Nov;27(11):921.e1-921.e10       18 Citations
1Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. (ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, Džavík V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, García-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, Knudson MM, Kornblith AE, Krishnan V, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Lima FG, Linstrum K, Litton E, Lopez-Sendon J, Lopez-Sendon Moreno JL, Lother SA, Malhotra S, Marcos M, Saud Marinez A, Marshall JC, Marten N, Matthay MA, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Moore SC, Morillo Guerrero R, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nunez-Garcia B, Pandey A, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pérez González YS, Pompilio M, Prekker ME, Quigley JG, Rost NS, Rowan K, Santos FO, Santos M, Olombrada Santos M, Satterwhite L, Saunders CT, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Shankar-Hari M, Sheehan JP, Singhal AB, Solvason D, Stanworth SJ, Tritschler T, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Wells BJ, Widmer RJ, Wilson JG, Yuriditsky E, Zampieri FG, Angus DC, McArthur CJ, Webb SA, Farkouh ME, Hochman JS, Zarychanski R) N Engl J Med 2021 Aug 26;385(9):790-802       712 Citations
1Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era. (Karmali R, Switchenko JM, Goyal S, Shanmugasundaram K, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Epperla N, Mathews S, Burkart M, Sawalha Y, Hill BT, Ghosh N, Park SI, Bond DA, Maddocks KJ, Badar T, Fenske TS, Hamadani M, Guo J, Malecek M, Kahl BS, Martin P, Blum KA, Flowers CR, Cohen JB) Am J Hematol 2021 Nov 01;96(11):1374-1384       15 Citations
1Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma. (Mohan M, Szabo A, Yarlagadda N, Gundarlapalli S, Thanendrarajan S, Kendrick S, Schinke C, Alapat D, Sawyer J, Tian E, Tricot G, van Rhee F, Zangari M) Am J Hematol 2021 Sep 01;96(9):E341-E344       4 Citations
1KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma. (Alsouqi A, Khan M, Dhakal B, Du L, Harrell S, Hari P, Cornell RF) Clin Lymphoma Myeloma Leuk 2021 Aug;21(8):526-535       17 Citations
1Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. (Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, HRS-HARMONY study investigators) Clin Transl Gastroenterol 2021 May 11;12(5):e00359       83 Citations
1Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery. (Jackson RS, Stepan K, Bollig C, Sharma RK, Patel M, Massa S, Puram SV, Zevallos JP, Pipkorn P, Zenga J) Otolaryngol Head Neck Surg 2021 Nov;165(5):682-689       7 Citations
1A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C) Br J Cancer 2021 May;124(10):1690-1698       22 Citations
1Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure. (Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, Radbel J, Green A, Sutherland A, Leonberg-Yoo A, Shehata A, Schenck EJ, Short SAP, Hernán MA, Chan L, Leaf DE, STOP-COVID Investigators) Crit Care Med 2021 Jul 01;49(7):1026-1037       74 Citations
3Pelvic Injury Risk Curves for the Military Populations From Lateral Impact. (Yoganandan N, Rooks TF, Chancey VC, Pintar FA, Banerjee A) Mil Med 2021 Jan 25;186(Suppl 1):424-429       1 Citation
1High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. (Okamura R, Piccioni DE, Boichard A, Lee S, Jimenez RE, Sicklick JK, Kato S, Kurzrock R) Int J Cancer 2021 Jun 01;148(11):2839-2847       27 Citations
1Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients? (Carter TM, Strassle PD, Ollila DW, Stitzenberg KB, Meyers MO, Maduekwe UN) Am J Surg 2021 Apr;221(4):706-711       10 Citations
1Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch. (Yuan B, Clark CA, Wu B, Yang J, Drerup JM, Li T, Jin VX, Hu Y, Curiel TJ, Li R) J Immunother Cancer 2021 Jan;9(1)       26 Citations
1Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. (Ong G, Pibarot P, Redfors B, Weissman NJ, Jaber WA, Makkar RR, Lerakis S, Gopal D, Khalique O, Kodali SK, Thourani VH, Anwaruddin S, McAndrew T, Zhang Y, Alu MC, Douglas PS, Hahn RT) J Am Coll Cardiol 2020 Dec 22;76(25):2940-2951       31 Citations
1Pediatric HCT in Florida (2014 -2016): A report from the FPBCC. (Chellapandian D, Sunkersett G, Oshrine B, Galvez Silva J, Ziga E, Alperstein W, Joyce M, Katzenstein H, Godder K, Castillo P, Barredo J, Fort J, Shaw PH, Nieder ML, Cline J, Yang F, Horn B) Pediatr Transplant 2021 Aug;25(5):e13931       1 Citation
2An Improved Method for Developing Injury Risk Curves Using the Brier Metric Score. (Hostetler ZS, Hsu FC, Yoganandan N, Pintar FA, Banerjee A, Voo L, Gayzik FS) Ann Biomed Eng 2021 Nov;49(11):3091-3098       4 Citations
3Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? (Shah NN, Ahn KW, Litovich C, He Y, Sauter C, Fenske TS, Hamadani M) Blood 2021 Mar 11;137(10):1416-1423       61 Citations
3Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. (Bona K, Brazauskas R, He N, Lehmann L, Abdel-Azim H, Ahmed IA, Al-Homsi AS, Aljurf M, Arnold SD, Badawy SM, Battiwalla M, Beattie S, Bhatt NS, Dalal J, Dandoy CE, Diaz MA, Frangoul HA, Freytes CO, Ganguly S, George B, Gomez-Almaguer D, Hahn T, Kamble RT, Knight JM, LeMaistre CF, Law J, Lazarus HM, Majhail NS, Olsson RF, Preussler J, Savani BN, Schears R, Seo S, Sharma A, Srivastava A, Steinberg A, Szwajcer D, Wirk B, Yoshimi A, Khera N, Wood WA, Hashmi S, Duncan CN, Saber W) Blood 2021 Jan 28;137(4):556-568       46 Citations
1A dependent Dirichlet process model for survival data with competing risks. (Shi Y, Laud P, Neuner J) Lifetime Data Anal 2021 Jan;27(1):156-176       3 Citations
1Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran. (Samsami M, Mehravaran E, Tabarsi P, Javadi A, Arsang-Jang S, Komaki A, Taheri M, Ghafouri-Fard S) Hum Antibodies 2021;29(1):49-54       4 Citations
1Rationale and methods of the Advanced R2Eperfusion STrategies for Refractory Cardiac Arrest (ARREST) trial. (Yannopoulos D, Kalra R, Kosmopoulos M, Walser E, Bartos JA, Murray TA, Connett JE, Aufderheide TP) Am Heart J 2020 Nov;229:29-39       29 Citations
1Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. (Charo LM, Eskander RN, Okamura R, Patel SP, Nikanjam M, Lanman RB, Piccioni DE, Kato S, McHale MT, Kurzrock R) Mol Oncol 2021 Jan;15(1):67-79       39 Citations
1High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. (Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R) Mol Cancer Ther 2020 Oct;19(10):2139-2145       60 Citations
3High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. (Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN) Surgery 2020 Oct;168(4):760-767       7 Citations
1High-Performance Trauma Centers in a Single-State Trauma System : Big Saves or Marginal Gains? (Hatchimonji JS, Kaufman EJ, Young AJ, Smith BP, Xiong R, Reilly PM, Holena DN) Am Surg 2020 Jul;86(7):766-772       3 Citations
1Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers. (Okamura R, Kurzrock R, Mallory RJ, Fanta PT, Burgoyne AM, Clary BM, Kato S, Sicklick JK) Int J Cancer 2021 Feb 01;148(3):702-712       55 Citations
4Twenty-four-hour versus clinic blood pressure levels as predictors of long-term cardiovascular and renal disease outcomes among African Americans. (Kidambi S, Wang T, Chelius T, Nunuk I, Agarwal P, Laud P, Mattson D, Cowley AW Jr, Liang M, Kotchen T) Sci Rep 2020 Jul 15;10(1):11685       6 Citations
1Malnutrition and overall survival in older patients with cancer. (Zhang X, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ) Clin Nutr 2021 Mar;40(3):966-977       42 Citations
2Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant. (Ghosh N, Ahmed S, Ahn KW, Khanal M, Litovich C, Aljurf M, Bacher VU, Bredeson C, Epperla N, Farhadfar N, Freytes CO, Ganguly S, Haverkos B, Inwards D, Kamble RT, Lazarus HM, Lekakis L, Murthy HS, Nishihori T, Ramakrishnan P, Rizzieri DA, Yared JA, Kharfan-Dabaja MA, Sureda A, Hamadani M) JAMA Oncol 2020 Jul 01;6(7):1011-1018       48 Citations
1MHC-I genotype and tumor mutational burden predict response to immunotherapy. (Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R) Genome Med 2020 May 19;12(1):45       90 Citations
1Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. (Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J) Clin Cancer Res 2020 Sep 01;26(17):4643-4650       62 Citations
7Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166       44 Citations
2Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. (Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC) J Surg Oncol 2020 Aug;122(2):176-182       11 Citations
6Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. (Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):1312-1317       53 Citations
1KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. (Wang M, Munoz J, Goy A, Locke FL, Jacobson CA, Hill BT, Timmerman JM, Holmes H, Jaglowski S, Flinn IW, McSweeney PA, Miklos DB, Pagel JM, Kersten MJ, Milpied N, Fung H, Topp MS, Houot R, Beitinjaneh A, Peng W, Zheng L, Rossi JM, Jain RK, Rao AV, Reagan PM) N Engl J Med 2020 Apr 02;382(14):1331-1342       1402 Citations
1The Changing Landscape of Treatment in Acute Myeloid Leukemia. (Koenig K, Mims A, Levis MJ, Horowitz MM) Am Soc Clin Oncol Educ Book 2020 Mar;40:1-12    
2Pneumonectomy for Pediatric Tumors-a Pediatric Surgical Oncology Research Collaborative Study. (Polites SF, Heaton TE, LaQuaglia MP, Kim ES, Barry WE, Goodhue CJ, Murphy AJ, Davidoff AM, Langham MR, Meyers RL, Short SS, Lautz TB, Glick RD, Vasudevan SA, Bence CM, Lal DR, Baertschiger RM, Emr B, Malek MM, Dasgupta R) Ann Surg 2021 Dec 01;274(6):e605-e609       8 Citations
1Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates. (Szerlip M, Anwaruddin S, Aronow HD, Cohen MG, Daniels MJ, Dehghani P, Drachman DE, Elmariah S, Feldman DN, Garcia S, Giri J, Kaul P, Kapur NK, Kumbhani DJ, Meraj PM, Morray B, Nayak KR, Parikh SA, Sakhuja R, Schussler JM, Seto A, Shah B, Swaminathan RV, Zidar DA, Naidu SS) Catheter Cardiovasc Interv 2020 Sep 01;96(3):586-597       85 Citations
2The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence. (Winn AN, Fergestrom NM, Pezzin LE, Laud PW, Neuner JM) Pharmacoepidemiol Drug Saf 2020 May;29(5):550-557       3 Citations
2Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. (Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative) J Surg Oncol 2020 Jun;121(7):1140-1147       11 Citations
8Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them. (Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN) Biol Blood Marrow Transplant 2020 Jul;26(7):1288-1297       14 Citations
1Multimorbidity and mortality risk in hospitalized adults with chronic inflammatory skin disease in the United States. (Narla S, Silverberg JI) Arch Dermatol Res 2020 Sep;312(7):507-512       7 Citations
2Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. (Jagadeesh D, Majhail NS, He Y, Ahn KW, Litovich C, Ahmed S, Aljurf M, Bacher U, Badawy SM, Bejanyan N, Cairo M, Cerny J, Epperla N, Farhadfar N, Freytes CO, Gale RP, Haverkos B, Hossain N, Inwards D, Kamble RT, Kenkre VP, Lazarus HM, Lazaryan A, Lekakis L, Mei M, Murthy HS, Mussetti A, Nathan S, Nishihori T, Olsson RF, Ramakrishnan Geethakumari P, Savani BN, Yared JA, Fenske TS, Kharfan-Dabaja MA, Sureda A, Hamadani M) Cancer 2020 May 15;126(10):2279-2287       18 Citations
1Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study. (Gorga SM, Sahay RD, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Zappitelli M, Gist KM, Gien J, Basu RK, Jetton JG, Murphy HJ, King E, Fleming GM, Selewski DT) Pediatr Nephrol 2020 May;35(5):871-882       62 Citations
3Pelvis injury risk curves in side impacts from human cadaver experiments using survival analysis and Brier score metrics. (Yoganandan N, Humm JR, DeVogel N, Banerjee A, Pintar FA, Somers JT) Traffic Inj Prev 2019;20(sup2):S137-S142       3 Citations
2Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point. (Martens MJ, Logan BR) Lifetime Data Anal 2020 Jul;26(3):603-623       1 Citation
1Lymphatic-type "Angiosarcoma" With Prominent Lymphocytic Infiltrate. (Martinez AP, Zapata M, North PE, Folpe AL, Weiss SW) Am J Surg Pathol 2020 Feb;44(2):271-279       8 Citations
1Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. (Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC) Ann Surg Oncol 2020 Apr;27(4):1156-1163       8 Citations
1Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy. (Shee K, Wells JD, Jiang A, Miller TW) PLoS One 2019;14(11):e0224267       37 Citations
4An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis. (Badar T, Dhakal B, Szabo A, Padmanabhan A, Johnson BD, Heidtke S, Esselmann J, Chhabra S, Hamadani M, Hari P, D'Souza A) J Clin Apher 2019 Dec;34(6):686-691       3 Citations
1Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. (González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ, PRIMA/ENGOT-OV26/GOG-3012 Investigators) N Engl J Med 2019 Dec 19;381(25):2391-2402       1697 Citations
1Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. (Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM) Radiother Oncol 2019 Dec;141:137-143       11 Citations
1Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. (Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B) Ann Thorac Surg 2020 Feb;109(2):404-411       10 Citations
1Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. (Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, Gitlin SD, Kaminski M, Cusick A, Phillips T, Sood S, Talpaz M, Quiery A, Boonstra PS, Wilcox RA) Lancet Haematol 2019 Dec;6(12):e630-e637       225 Citations
2Related and unrelated donor transplantation for β-thalassemia major: results of an international survey. (Li C, Mathews V, Kim S, George B, Hebert K, Jiang H, Li C, Zhu Y, Keesler DA, Boelens JJ, Dvorak CC, Agarwal R, Auletta JJ, Goyal RK, Hanna R, Kasow K, Shenoy S, Smith AR, Walters MC, Eapen M) Blood Adv 2019 Sep 10;3(17):2562-2570       66 Citations
1Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. (Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C) Head Neck 2019 Nov;41(11):3924-3932       10 Citations
1Smoking Significantly Impacts Persistence Rates in Embolized Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia. (Haddad MM, Bendel EC, Harmsen WS, Iyer VN, Misra S) Radiology 2019 Sep;292(3):762-770       9 Citations
1Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. (Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR) Blood Adv 2019 Aug 13;3(15):2250-2263       39 Citations
1Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer. (Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB) Ann Surg 2019 Sep;270(3):400-413       138 Citations
3Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. (Kim HT, Ahn KW, Hu ZH, Davids MS, Volpe VO, Antin JH, Sorror ML, Shadman M, Press O, Pidala J, Hogan W, Negrin R, Devine S, Uberti J, Agura E, Nash R, Mehta J, McGuirk J, Forman S, Langston A, Giralt SA, Perales MA, Battiwalla M, Hale GA, Gale RP, Marks DI, Hamadani M, Ganguly S, Bacher U, Lazarus H, Reshef R, Hildebrandt GC, Inamoto Y, Cahn JY, Solh M, Kharfan-Dabaja MA, Ghosh N, Saad A, Aljurf M, Schouten HC, Hill BT, Pawarode A, Kindwall-Keller T, Saba N, Copelan EA, Nathan S, Beitinjaneh A, Savani BN, Cerny J, Grunwald MR, Yared J, Wirk BM, Nishihori T, Chhabra S, Olsson RF, Bashey A, Gergis U, Popat U, Sobecks R, Alyea E, Saber W, Brown JR) Clin Cancer Res 2019 Aug 15;25(16):5143-5155       12 Citations
6Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer. (Zenga J, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Laryngoscope 2020 Mar;130(3):666-671       16 Citations
2Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. (Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, Cahn JY, Cairo M, Ciurea S, Copelan E, Cutler C, Daly A, Diaz MA, Farhadfar N, Gale RP, Ganguly S, Grunwald MR, Hahn T, Hashmi S, Hildebrandt GC, Holland HK, Hossain N, Kanakry CG, Kharfan-Dabaja MA, Khera N, Koc Y, Lazarus HM, Lee JW, Maertens J, Martino R, McGuirk J, Munker R, Murthy HS, Nakamura R, Nathan S, Nishihori T, Palmisiano N, Patel S, Pidala J, Olin R, Olsson RF, Oran B, Ringden O, Rizzieri D, Rowe J, Savoie ML, Schultz KR, Seo S, Shaffer BC, Singh A, Solh M, Stockerl-Goldstein K, Verdonck LF, Wagner J, Waller EK, De Lima M, Sandmaier BM, Litzow M, Weisdorf D, Romee R, Saber W) Blood Adv 2019 Jun 25;3(12):1826-1836       106 Citations
1Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting. (Mardinian K, Okamura R, Kato S, Kurzrock R) Int J Cancer 2020 Jan 15;146(2):566-576       18 Citations
1Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. (Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD) Cancer 2019 Aug 01;125(15):2610-2620       63 Citations
2Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. (Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC) J Surg Res 2019 Oct;242:23-30       27 Citations
1Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model. (Golchin S, Alimohammadi R, Rostami Nejad M, Jalali SA) J Cell Physiol 2019 Nov;234(11):19866-19874       29 Citations
1Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. (Mayor NP, Hayhurst JD, Turner TR, Szydlo RM, Shaw BE, Bultitude WP, Sayno JR, Tavarozzi F, Latham K, Anthias C, Robinson J, Braund H, Danby R, Perry J, Wilson MC, Bloor AJ, McQuaker IG, MacKinnon S, Marks DI, Pagliuca A, Potter MN, Potter VT, Russell NH, Thomson KJ, Madrigal JA, Marsh SGE) Biol Blood Marrow Transplant 2019 Mar;25(3):443-450       95 Citations
2The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. (Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, Camitta B, Verdonck LF, Dandoy C, Diaz MA, Savani BN, George B, Liesveld J, McGuirk J, Byrne M, Grunwald MR, Drobyski WR, Pulsipher MA, Abdel-Azim H, Prestidge T, Wieduwilt MJ, Martino R, Norkin M, Beitinjaneh A, Seo S, Nishihori T, Wirk B, Frangoul H, Bashey A, Mori S, Marks DI, Bachanova V) Blood Adv 2019 Feb 26;3(4):670-680       70 Citations
2Cardiac Arrest Outcomes in Children With Preexisting Neurobehavioral Impairment. (Christensen JR, Slomine BS, Silverstein FS, Page K, Holubkov R, Dean JM, Moler FW, Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) Trial Investigators) Pediatr Crit Care Med 2019 Jun;20(6):510-517       6 Citations
1Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study. (Garcia-Manero G, Abaza Y, Takahashi K, Medeiros BC, Arellano M, Khaled SK, Patnaik M, Odenike O, Sayar H, Tummala M, Patel P, Maness-Harris L, Stuart R, Traer E, Karamlou K, Yacoub A, Ghalie R, Giorgino R, Atallah E) Blood Adv 2019 Feb 26;3(4):508-518       71 Citations
3Hierarchical process using Brier Score Metrics for lower leg injury risk curves in vertical impact. (DeVogel N, Yoganandan N, Banerjee A, Pintar FA) BMJ Mil Health 2020 Oct;166(5):318-323       3 Citations
2Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. (Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C) J Immunother Cancer 2019 Feb 01;7(1):27       71 Citations
1Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier. (Chen Y, Wang Y, Salas LA, Miller TW, Mark K, Marotti JD, Kettenbach AN, Cheng C, Christensen BC) Breast Cancer Res 2019 Jan 25;21(1):14       9 Citations
1Pediatric out-of-hospital cardiac arrest: Time to goal target temperature and outcomes. (Moler FW, Silverstein FS, Nadkarni VM, Meert KL, Shah SH, Slomine B, Christensen J, Holubkov R, Page K, Dean JM, THAPCA Trial Investigators) Resuscitation 2019 Feb;135:88-97       7 Citations
1Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. (Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R) Mol Cancer Ther 2019 Feb;18(2):448-458       69 Citations
1Comparative survival and role of STS score in aortic paravalvular leak after SAVR or TAVR: a retrospective study from the USA. (Padang R, Ali M, Greason KL, Scott CG, Indrabhinduwat M, Rihal CS, Eleid MF, Nkomo VT, Pellikka PA, Pislaru SV) BMJ Open 2018 Dec 09;8(12):e022437       11 Citations
1Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. (Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT, JULIET Investigators) N Engl J Med 2019 Jan 03;380(1):45-56       3102 Citations
1Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. (Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ Jr, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP) Int J Radiat Oncol Biol Phys 2019 Mar 15;103(4):878-886       11 Citations
1Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease? (Vaughn JL, Zhao Q, Epperla N, Puto M, Roddy J, Elder P, Blum W, Klisovic R, Jaglowski S, Penza S, William B, Andritsos L, Brammer JE, Hofmeister C, Efebera Y, Benson D, Devine S, Cataland S, Vasu S) Bone Marrow Transplant 2019 Jun;54(6):913-916       2 Citations
1Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. (Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, Yehya N, Willson D, Kneyber MCJ, Lillie J, Fernandez A, Newth CJL, Jouvet P, Thomas NJ, Pediatric Acute Respiratory Distress syndrome Incidence and Epidemiology (PARDIE) Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network) Lancet Respir Med 2019 Feb;7(2):115-128       300 Citations
1Longer storage of red blood cells does not affect mortality in transfused liver transplant recipients. (Kwon JH, Han S, Cho D, Spahn DR, Ko JS, Kim DY, Jun JH, Gwak MS, Kim GS) Transfusion 2018 Nov;58(11):2529-2537       3 Citations
1Variation in Survival After Out-of-Hospital Cardiac Arrest Between Emergency Medical Services Agencies. (Okubo M, Schmicker RH, Wallace DJ, Idris AH, Nichol G, Austin MA, Grunau B, Wittwer LK, Richmond N, Morrison LJ, Kurz MC, Cheskes S, Kudenchuk PJ, Zive DM, Aufderheide TP, Wang HE, Herren H, Vaillancourt C, Davis DP, Vilke GM, Scheuermeyer FX, Weisfeldt ML, Elmer J, Colella R, Callaway CW, Resuscitation Outcomes Consortium Investigators) JAMA Cardiol 2018 Oct 01;3(10):989-999       62 Citations
1Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma. (Maffini E, Storer BE, Sandmaier BM, Bruno B, Sahebi F, Shizuru JA, Chauncey TR, Hari P, Lange T, Pulsipher MA, McSweeney PA, Holmberg L, Becker PS, Green DJ, Mielcarek M, Maloney DG, Storb R) Haematologica 2019 Feb;104(2):380-391       26 Citations
1Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. (Zare M, Hadi F, Alivand MR) Per Med 2018 Sep;15(5):361-370       1 Citation
1Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia. (Rice C, Eikema DJ, Marsh JCW, Knol C, Hebert K, Putter H, Peterson E, Deeg HJ, Halkes S, Pidala J, Anderlini P, Tischer J, Kroger N, McDonald A, Antin JH, Schaap NP, Hallek M, Einsele H, Mathews V, Kapoor N, Boelens JJ, Mufti GJ, Potter V, Pefault de la Tour R, Eapen M, Dufour C) Biol Blood Marrow Transplant 2019 Mar;25(3):488-495       30 Citations
1Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. (Marsh RA, Hebert KM, Keesler D, Boelens JJ, Dvorak CC, Eckrich MJ, Kapoor N, Parikh S, Eapen M) J Allergy Clin Immunol 2018 Dec;142(6):2004-2007       16 Citations
1Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. (Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW) FASEB J 2019 Feb;33(2):1644-1657       16 Citations
1Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial. (Mato AR, Roeker LE, Allan JN, Pagel JM, Brander DM, Hill BT, Cheson BD, Furman RR, Lamanna N, Tam CS, Handunnetti S, Jacobs R, Lansigan F, Bhavsar E, Barr PM, Shadman M, Skarbnik AP, Goy A, Beach DF, Svoboda J, Pu JJ, Sehgal AR, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Rhodes J, Ujjani CS, Nabhan C) Am J Hematol 2018 Nov;93(11):1394-1401       60 Citations
1Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. (Wang TS, Sosa JA) Nat Rev Endocrinol 2018 Nov;14(11):670-683       192 Citations
1Improving Surveillance of Traumatic Thoracic Aortic Injuries Repaired with Thoracic Endovascular Graft Placement. (Ludwig NA, Bhutiani N, Linsky PL, Dwivedi AJ, Bozeman MC) Am Surg 2018 Jul 01;84(7):1129-1132    
4Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67       7 Citations
1Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. (Dong J, Gu X, El-Serag HB, Thrift AP) Clin Gastroenterol Hepatol 2019 Mar;17(4):657-665.e13       26 Citations
2Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. (Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA) Blood 2018 Sep 27;132(13):1438-1451       90 Citations
1Analysis of multiple survival events in generalized case-cohort designs. (Kim S, Zeng D, Cai J) Biometrics 2018 Dec;74(4):1250-1260       13 Citations
1Testing for center effects on survival and competing risks outcomes using pseudo-value regression. (Wang Y, Logan BR) Lifetime Data Anal 2019 Apr;25(2):206-228       1 Citation
1Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. (Calzada O, Switchenko JM, Maly JJ, Blum KA, Grover N, Mathews S, Park SI, Gordon M, Danilov A, Epperla N, Fenske TS, Hamadani M, Flowers CR, Cohen JB) Leuk Lymphoma 2018 Dec;59(12):2862-2870       13 Citations
1Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness. (Randolph AG, Xu R, Novak T, Newhams MM, Bubeck Wardenburg J, Weiss SL, Sanders RC, Thomas NJ, Hall MW, Tarquinio KM, Cvijanovich N, Gedeit RG, Truemper EJ, Markovitz B, Hartman ME, Ackerman KG, Giuliano JS Jr, Shein SL, Moffitt KL, Pediatric Intensive Care Influenza Investigators from the Pediatric Acute Lung Injury and Sepsis Investigator’s Network) Clin Infect Dis 2019 Jan 18;68(3):365-372       35 Citations
1Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States. (Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C) Haematologica 2018 Sep;103(9):1511-1517       145 Citations
1Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract. (Ganetsky A, Frey NV, Hexner EO, Loren AW, Gill SI, Luger SM, Mangan JK, Martin ME, Babushok DV, Drobyski WR, Smith J, Timlin C, Freyer CW, Stadtmauer EA, Porter DL) Bone Marrow Transplant 2019 Feb;54(2):212-217       36 Citations
1Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. (Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M) J Invest Dermatol 2018 Nov;138(11):2315-2321       109 Citations
2Application of resampling techniques to improve the quality of survival analysis risk curves for human frontal bone fracture. (DeVogel N, Banerjee A, Yoganandan N) Clin Biomech (Bristol) 2019 Apr;64:28-34       3 Citations
2Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. (Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C) Biol Blood Marrow Transplant 2018 Aug;24(8):1651-1656       19 Citations
2Prenatal counseling and parental decision-making following a fetal diagnosis of trisomy 13 or 18. (Winn P, Acharya K, Peterson E, Leuthner S) J Perinatol 2018 Jul;38(7):788-796       17 Citations
4Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. (Shah NN, Ahn KW, Litovich C, Fenske TS, Ahmed S, Battiwalla M, Bejanyan N, Dahi PB, Bolaños-Meade J, Chen AI, Ciurea SO, Bachanova V, DeFilipp Z, Epperla N, Farhadfar N, Herrera AF, Haverkos BM, Holmberg L, Hossain NM, Kharfan-Dabaja MA, Kenkre VP, Lazarus HM, Murthy HS, Nishihori T, Rezvani AR, D'Souza A, Savani BN, Ulrickson ML, Waller EK, Sureda A, Smith SM, Hamadani M) Blood Adv 2018 Apr 24;2(8):933-940       26 Citations
11Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. (Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S) Biol Blood Marrow Transplant 2018 Aug;24(8):1664-1670       37 Citations
1Reduced Right Ventricular Fractional Area Change, Strain, and Strain Rate before Bidirectional Cavopulmonary Anastomosis is Associated with Medium-Term Mortality for Children with Hypoplastic Left Heart Syndrome. (Lin LQ, Conway J, Alvarez S, Goot B, Serrano-Lomelin J, Colen T, Tham EB, Kutty S, Li L, Khoo NS) J Am Soc Echocardiogr 2018 Jul;31(7):831-842       32 Citations
1Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial. (Bishawi M, Hattler B, Almassi GH, Spertus JA, Quin JA, Collins JF, Grover FL, Shroyer AL, VA #517 Randomized On/Off Bypass (ROOBY) Study Group) Am Heart J 2018 Apr;198:33-38       20 Citations
1The importance of greater speed in drug development for advanced malignancies. (Stewart DJ, Stewart AA, Wheatley-Price P, Batist G, Kantarjian HM, Schiller J, Clemons M, Bradford JP, Gillespie L, Kurzrock R) Cancer Med 2018 May;7(5):1824-1836       31 Citations
1Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies. (Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX, Donor Nephrectomy Outcomes Research (DONOR) Network) Am J Kidney Dis 2018 Oct;72(4):483-498       47 Citations
2Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. (Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi SK, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad AA, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W) Biol Blood Marrow Transplant 2018 Sep;24(9):1928-1935       3 Citations
3Role of disc area and trabecular bone density on lumbar spinal column fracture risk curves under vertical impact. (Yoganandan N, Moore J, Pintar FA, Banerjee A, DeVogel N, Zhang J) J Biomech 2018 Apr 27;72:90-98       21 Citations
1Implications of postoperative pulmonary aspiration following major urologic surgery. (Kirshenbaum EJ, Blackwell RH, Li B, Kothari AN, Kuo PC, Flanigan RC, Gorbonos A, Gupta GN) Can J Urol 2018 Feb;25(1):9186-9192       3 Citations
1A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. (Rudolph M, Sizemore ST, Lu Y, Teng KY, Basree MM, Reinbolt R, Timmers CD, Leone G, Ostrowski MC, Majumder S, Ramaswamy B) Breast Cancer Res Treat 2018 Jun;169(3):457-467       8 Citations
1A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. (Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J) J Antimicrob Chemother 2018 May 01;73(5):1402-1407       39 Citations
3Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ) Biol Blood Marrow Transplant 2018 May;24(5):1049-1056       132 Citations
1Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity. (Lee KW, Han S, Lee S, Cha HH, Ahn S, Ahn HS, Ko JS, Gwak MS, Kim GS, Joh JW, Lee SK, Choi GS) Transplantation 2018 Jul;102(7):1115-1123       17 Citations
2Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. (McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M) Blood Adv 2018 Feb 13;2(3):299-307       74 Citations
4Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation. (Epperla N, Hamadani M, Ahn KW, He F, Kodali D, Kleman A, Hari PN, Pasquini M, Fenske TS, Craig MD, Kanate AS, Bachanova V) Biol Blood Marrow Transplant 2018 May;24(5):983-988       4 Citations
2Survival Analysis-Based Human Head Injury Risk Curves: Focus on Skull Fracture. (Yoganandan N, Banerjee A) J Neurotrauma 2018 Jun 01;35(11):1272-1279       18 Citations
1Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML). (Advani AS, Li H, Michaelis LC, Medeiros BC, Liedtke M, List AF, O'Dwyer K, Othus M, Erba HP, Appelbaum FR) Leuk Res 2018 Apr;67:17-20       25 Citations
1NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. (Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr) J Neurooncol 2018 Mar;137(1):39-47       30 Citations
3Human Foot-Ankle Injuries and Associated Risk Curves from Under Body Blast Loading Conditions. (Chirvi S, Pintar F, Yoganandan N, Banerjee A, Schlick M, Curry W, Voo L) Stapp Car Crash J 2017 Nov;61:157-173       19 Citations
2Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck. (Awan MJ, Nedzi L, Wang D, Tumati V, Sumer B, Xie XJ, Smith I, Truelson J, Hughes R, Myers LL, Lavertu P, Wong S, Yao M) Ann Oncol 2018 Apr 01;29(4):998-1003       21 Citations
1Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. (Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Peter Gale R, Lazarus HM, Ustun C, Copelan E, Ky Hamilton B, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ) Biol Blood Marrow Transplant 2018 May;24(5):945-955       7 Citations
2Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. (Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M) Biol Blood Marrow Transplant 2018 Jun;24(6):1163-1171       110 Citations
1Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466       18 Citations
1Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury. (Vedantam A, Robertson CS, Gopinath SP) Neurosurg Focus 2017 Nov;43(5):E2       65 Citations
4Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma. (Epperla N, Ahn KW, Armand P, Jaglowski S, Ahmed S, Kenkre VP, Savani B, Jagasia M, Shah NN, Fenske TS, Sureda A, Smith SM, Hamadani M) Biol Blood Marrow Transplant 2018 Jan;24(1):78-85       9 Citations
1Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. (Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, Burroughs L, Chandra S, Kletzel M, Thakar M, Connelly J, Cuvelier G, Davila Saldana BJ, Shereck E, Knutsen A, Sullivan KE, DeSantes K, Gillio A, Haddad E, Petrovic A, Quigg T, Smith AR, Stenger E, Yin Z, Shearer WT, Fleisher T, Buckley RH, Dvorak CC) Blood 2017 Dec 21;130(25):2718-2727       223 Citations
1Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. (Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP) Cell 2017 Oct 19;171(3):540-556.e25       1708 Citations
2Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis. (Mahindra A, Hari P, Fraser R, Fei M, Huang J, Berdeja J, Callander N, Costa L, Diaz MA, Freytes C, Gale RP, Girnius S, Holmberg L, Kharfan-Dabaja M, Kumar S, Kyle R, Lazarus H, Lee C, Maiolino A, Moreb J, Nishihori T, Pawarode A, Saad A, Savani BN, Schriber J, William B, Wirk BM, Krishnan A, Nieto Y, D'Souza A) Bone Marrow Transplant 2017 Dec;52(12):1616-1622       51 Citations
1Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysis. (Malogolowkin MH, Hemmer MT, Le-Rademacher J, Hale GA, Mehta PA, Smith AR, Kitko C, Abraham A, Abdel-Azim H, Dandoy C, Angel Diaz M, Gale RP, Guilcher G, Hayashi R, Jodele S, Kasow KA, MacMillian ML, Thakar M, Wirk BM, Woolfrey A, Thiel EL) Bone Marrow Transplant 2017 Nov;52(11):1549-1555       25 Citations
3Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. (Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL) Lancet Haematol 2017 Sep;4(9):e431-e442       143 Citations
2Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. (Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M) Br J Haematol 2018 Sep;182(6):916-920       61 Citations
1A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (Vergote IB, Smith DC, Berger R, Kurzrock R, Vogelzang NJ, Sella A, Wheler J, Lee Y, Foster PG, Weitzman R, Buckanovich RJ) Eur J Cancer 2017 Sep;83:229-236       30 Citations
3Role of age and injury mechanism on cervical spine injury tolerance from head contact loading. (Yoganandan N, Chirvi S, Voo L, Pintar FA, Banerjee A) Traffic Inj Prev 2018 Feb 17;19(2):165-172       10 Citations
1Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare population. (McCarthy FH, Spragan DD, Savino D, Dibble T, Hoedt AC, McDermott KM, Bavaria JE, Herrmann HC, Anwaruddin S, Giri J, Szeto WY, Groeneveld PW, Desai ND) J Thorac Cardiovasc Surg 2017 Oct;154(4):1224-1232.e1       28 Citations
4Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014. (D'Souza A, Zhang MJ, Huang J, Fei M, Pasquini M, Hamadani M, Hari P) Leukemia 2017 Sep;31(9):1998-2000       14 Citations
1Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors. (Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS) Ann Surg 2018 Dec;268(6):1043-1050       22 Citations
1Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. (Kumar SK, Dimopoulos MA, Kastritis E, Terpos E, Nahi H, Goldschmidt H, Hillengass J, Leleu X, Beksac M, Alsina M, Oriol A, Cavo M, Ocio EM, Mateos MV, O'Donnell EK, Vij R, Lokhorst HM, van de Donk NWCJ, Min C, Mark T, Turesson I, Hansson M, Ludwig H, Jagannath S, Delforge M, Kyriakou C, Hari P, Mellqvist U, Usmani SZ, Dytfeld D, Badros AZ, Moreau P, Kim K, Otero PR, Lee JH, Shustik C, Waller D, Chng WJ, Ozaki S, Lee JJ, de la Rubia J, Eom HS, Rosinol L, Lahuerta JJ, Sureda A, Kim JS, Durie BGM) Leukemia 2017 Nov;31(11):2443-2448       288 Citations
3Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A) Lancet Haematol 2017 Jul;4(7):e325-e333       76 Citations
2Current Use and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Lee S, Zhu X, Pasquini M) Biol Blood Marrow Transplant 2017 Sep;23(9):1417-1421       217 Citations
3Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma. (Epperla N, Ahn KW, Ahmed S, Jagasia M, DiGilio A, Devine SM, Jaglowski S, Kennedy V, Rezvani AR, Smith SM, Sureda A, Fenske TS, Kharfan-Dabaja MA, Armand P, Hamadani M) J Hematol Oncol 2017 Jun 12;10(1):117       19 Citations
3Disparities in access to care and outcomes in patients with adrenocortical carcinoma. (Hammad AY, Yen TWF, Carr AA, Evans DB, Wang TS) J Surg Res 2017 Jun 01;213:138-146       13 Citations
1Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. (Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO) Clin Gastroenterol Hepatol 2017 Nov;15(11):1791-1799       96 Citations
3Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC) HPB (Oxford) 2017 Aug;19(8):659-666       88 Citations
1Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. (Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA) Surgery 2017 Sep;162(3):500-514       60 Citations
1Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. (Rodriguez JF, Packiam VT, Boysen WR, Johnson SC, Smith ZL, Smith ND, Shalhav AL, Steinberg GD) J Endourol 2017 Jul;31(7):661-665       53 Citations
1The Pennsylvania Trauma Outcomes Study Risk-Adjusted Mortality Model: Results of a Statewide Benchmarking Program. (Wiebe DJ, Holena DN, Delgado MK, McWilliams N, Altenburg J, Carr BG) Am Surg 2017 May 01;83(5):445-452       18 Citations
3Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation. (Bitan M, Ahn KW, Millard HR, Pulsipher MA, Abdel-Azim H, Auletta JJ, Brown V, Chan KW, Diaz MA, Dietz A, Vincent MG, Guilcher G, Hale GA, Hayashi RJ, Keating A, Mehta P, Myers K, Page K, Prestidge T, Shah NN, Smith AR, Woolfrey A, Thiel E, Davies SM, Eapen M) Biol Blood Marrow Transplant 2017 Sep;23(9):1523-1530       14 Citations
1Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493       107 Citations
2PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD. (Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, Kamdar M, Kanate AS, Saad A, Mehta A, Ganguly S, Fenske TS, Hari P, Lowsky R, Andritsos L, Jagasia M, Bashey A, Brown S, Bachanova V, Stephens D, Mineishi S, Nakamura R, Chen YB, Blazar BR, Gutman J, Devine SM) Blood 2017 Jul 13;130(2):221-228       210 Citations
1T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas. (Pollack SM, He Q, Yearley JH, Emerson R, Vignali M, Zhang Y, Redman MW, Baker KK, Cooper S, Donahue B, Loggers ET, Cranmer LD, Spraker MB, Seo YD, Pillarisetty VG, Ricciotti RW, Hoch BL, McClanahan TK, Murphy E, Blumenschein WM, Townson SM, Benzeno S, Riddell SR, Jones RL) Cancer 2017 Sep 01;123(17):3291-3304       222 Citations
2External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. (Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2017 Sep;116(3):307-312       17 Citations
3Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia. (Segal E, Martens M, Wang HL, Brazauskas R, Weisdorf D, Sandmaier BM, Khoury HJ, de Lima M, Saber W) Cancer 2017 Sep 01;123(17):3346-3355       23 Citations
2The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. (Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, O'Cathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK) Hepatology 2017 Aug;66(2):518-527       176 Citations
1Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. (Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH) Haematologica 2017 Jul;102(7):1291-1298       42 Citations
1Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes. (Gerds AT, Woo Ahn K, Hu ZH, Abdel-Azim H, Akpek G, Aljurf M, Ballen KK, Beitinjaneh A, Bacher U, Cahn JY, Chhabra S, Cutler C, Daly A, DeFilipp Z, Gale RP, Gergis U, Grunwald MR, Hale GA, Hamilton BK, Jagasia M, Kamble RT, Kindwall-Keller T, Nishihori T, Olsson RF, Ramanathan M, Saad AA, Solh M, Ustun C, Valcárcel D, Warlick E, Wirk BM, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W) Biol Blood Marrow Transplant 2017 Jun;23(6):971-979       19 Citations
2Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation. (Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu ZH, Spellman SR, Lee SJ, Verneris MR, Hsu K, Fleischhauer K, Cutler C, Antin JH, Neuberg D, Ebert BL) N Engl J Med 2017 Feb 09;376(6):536-547       617 Citations
3Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis. (Hamadani M, Kanate AS, DiGilio A, Ahn KW, Smith SM, Lee JW, Ayala E, Chao N, Hari P, Bolaños-Meade J, Gress R, Smedegaard Anderson N, Chen YB, Farooq U, Schiller G, Yared J, Sureda A, Fenske TS, Olteanu H) Biol Blood Marrow Transplant 2017 May;23(5):853-856       32 Citations
1Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation. (Berro M, Palau Nagore MV, Rivas MM, Longo P, Foncuberta C, Vitriú A, Remaggi G, Martínez Rolon J, Jaimovich G, Requejo A, Feldman L, Padros K, Rodríguez MB, Shaw BE, Larripa I, Belli CB, Kusminsky GD) Bone Marrow Transplant 2017 May;52(5):739-744       6 Citations
1Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus. (Nakagawa P, Masjoan-Juncos JX, Basha H, Janic B, Worou ME, Liao TD, Romero CA, Peterson EL, Carretero OA) Physiol Rep 2017 Jan;5(2)       11 Citations
2Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children. (Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, Gildea MR, Scholefield BR, Shankaran S, Hutchison JS, Berger JT, Ofori-Amanfo G, Newth CJ, Topjian A, Bennett KS, Koch JD, Pham N, Chanani NK, Pineda JA, Harrison R, Dalton HJ, Alten J, Schleien CL, Goodman DM, Zimmerman JJ, Bhalala US, Schwarz AJ, Porter MB, Shah S, Fink EL, McQuillen P, Wu T, Skellett S, Thomas NJ, Nowak JE, Baines PB, Pappachan J, Mathur M, Lloyd E, van der Jagt EW, Dobyns EL, Meyer MT, Sanders RC Jr, Clark AE, Dean JM, THAPCA Trial Investigators) N Engl J Med 2017 Jan 26;376(4):318-329       227 Citations
1Right Internal Mammary Artery Use in 140 Robotic Totally Endoscopic Coronary Bypass Cases: Toward Multiarterial Grafting. (Balkhy HH, Nathan S, Arnsdorf SE, Krienbring DJ) Innovations (Phila) 2017;12(1):9-14       47 Citations
1Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma. (Daud A, Kluger HM, Kurzrock R, Schimmoller F, Weitzman AL, Samuel TA, Moussa AH, Gordon MS, Shapiro GI) Br J Cancer 2017 Feb 14;116(4):432-440       63 Citations
1Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants. (Shaw BE, Mayor NP, Szydlo RM, Bultitude WP, Anthias C, Kirkland K, Perry J, Clark A, Mackinnon S, Marks DI, Pagliuca A, Potter MN, Russell NH, Thomson K, Madrigal JA, Marsh SGE) Bone Marrow Transplant 2017 May;52(5):717-725       54 Citations
3Major anomalies and birth-weight influence NICU interventions and mortality in infants with trisomy 13 or 18. (Acharya K, Leuthner S, Clark R, Nghiem-Rao TH, Spitzer A, Lagatta J) J Perinatol 2017 Apr;37(4):420-426       19 Citations
3Response to Letter to the Editor on "Deriving injury risk curves using survival analysis from biomechanical experiments", Journal of Biomechanics (in press). (Yoganandan N, Banerjee A, Hsu FC, Bass CR, Voo L, Pintar FA, Gayzik FS) J Biomech 2017 Feb 08;52:189-190       1 Citation
3Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 Dec 20;34(36):4398-4404       36 Citations
1Acute Leukemia of Ambiguous Lineage in Elderly Patients - Analysis of Survival Using Surveillance Epidemiology and End Results-Medicare Database. (Guru Murthy GS, Dhakal I, Lee JY, Mehta P) Clin Lymphoma Myeloma Leuk 2017 Feb;17(2):100-107       6 Citations
1Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. (Guru Murthy GS, Dhakal I, Mehta P) Leuk Lymphoma 2017 Jul;58(7):1648-1654       34 Citations
3The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. (Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research) Haematologica 2016 Nov;101(11):1426-1433       60 Citations
1Interferon Regulatory Factor 1 and Type I Interferon Cooperate To Control Acute Gammaherpesvirus Infection. (Mboko WP, Rekow MM, Ledwith MP, Lange PT, Schmitz KE, Anderson S, Tarakanova VL) J Virol 2017 Jan 01;91(1)       22 Citations
4Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma. (Cornell RF, Bachanova V, D'Souza A, Woo-Ahn K, Martens M, Huang J, Al-Homsi AS, Chhabra S, Copelan E, Diaz MA, Freytes CO, Gale RP, Ganguly S, Hamadani M, Hildebrandt G, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Saad A, Usmani S, Vesole DH, Yared J, Mark T, Nieto Y, Hari P) Biol Blood Marrow Transplant 2017 Jan;23(1):60-66       16 Citations
1Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. (Tran TB, Maithel SK, Pawlik TM, Wang TS, Hatzaras I, Phay JE, Fields RC, Weber SM, Sicklick JK, Yopp AC, Duh QY, Solorzano CC, Votanopoulos KI, Poultsides GA) J Am Coll Surg 2016 Dec;223(6):794-803       21 Citations
1Sodium nitroprusside enhanced cardiopulmonary resuscitation improves short term survival in a porcine model of ischemic refractory ventricular fibrillation. (Yannopoulos D, Bartos JA, George SA, Sideris G, Voicu S, Oestreich B, Matsuura T, Shekar K, Rees J, Aufderheide TP) Resuscitation 2017 Jan;110:6-11       17 Citations
1Oncologic progress for the treatment of parathyroid carcinoma is needed. (Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Surg Oncol 2016 Nov;114(6):708-713       34 Citations
1Failure-to-rescue after injury is associated with preventability: The results of mortality panel review of failure-to-rescue cases in trauma. (Kuo LE, Kaufman E, Hoffman RL, Pascual JL, Martin ND, Kelz RR, Holena DN) Surgery 2017 Mar;161(3):782-790       29 Citations
1The Impact of Advancing Age on Recurrence and Survival Following Major Hepatectomy for Colorectal Liver Metastases. (Bell R, Pandanaboyana S, Nisar S, Upasani V, Toogood G, Lodge JP, Prasad KR) J Gastrointest Surg 2017 Feb;21(2):266-274       7 Citations
3Deriving injury risk curves using survival analysis from biomechanical experiments. (Yoganandan N, Banerjee A, Hsu FC, Bass CR, Voo L, Pintar FA, Gayzik FS) J Biomech 2016 Oct 03;49(14):3260-3267       37 Citations
1Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER. (Subbiah IM, Wheler JJ, Hess KR, Hong DS, Naing A, Fu S, Kurzrock R, Tsimberidou AM) Int J Cancer 2017 Jan 01;140(1):208-215       9 Citations
2Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation. (Epperla N, Shah N, Hamadani M, Richardson K, Kapke JT, Patel A, Teegavarapu SP, Carrum G, Hari PN, Pingali SR, Karmali R, Fenske TS) Clin Lymphoma Myeloma Leuk 2016 Dec;16(12):672-678       7 Citations
1Staphylococcus aureus α-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children. (Yu KO, Randolph AG, Agan AA, Yip WK, Truemper EJ, Weiss SL, Ackerman KG, Schwarz AJ, Giuliano JS Jr, Hall MW, Bubeck Wardenburg J, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) PICFlu Study Group, PALISI PICFlu Study Group) J Infect Dis 2016 Dec 01;214(11):1638-1646       17 Citations
1Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma. (Zenga J, Jackson RS, Graboyes EM, Sinha P, Lindberg M, Martin EJ, Ma D, Thorstad WL, Rich JT, Moore EJ, Haughey BH) Laryngoscope 2017 Mar;127(3):623-630       23 Citations
1Actual 10-year survivors following resection of adrenocortical carcinoma. (Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn J, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Hatzaras I, Shenoy R, Pawlik TM, Norton JA, Poultsides GA) J Surg Oncol 2016 Dec;114(8):971-976       34 Citations
1Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. (Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB) Chest 2016 Dec;150(6):1251-1259       172 Citations
3Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589       109 Citations
1Characterizing the role of a high-volume cancer resection ecosystem on low-volume, high-quality surgical care. (Kothari AN, Blanco BA, Brownlee SA, Evans AE, Chang VA, Abood GJ, Settimi R, Raicu DS, Kuo PC) Surgery 2016 Oct;160(4):839-849       11 Citations
3Achieving low anastomotic leak rates utilizing clinical perfusion assessment. (Kream J, Ludwig KA, Ridolfi TJ, Peterson CY) Surgery 2016 Oct;160(4):960-967       21 Citations
2Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis. (Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazarus H, Lee C, Maziarz RT, Meehan K, Mikhael J, Nishihori T, Ramanathan M, Usmani S, Tay J, Vesole D, Wirk B, Yared J, Savani BN, Gasparetto C, Krishnan A, Mark T, Nieto Y, D'Souza A) Biol Blood Marrow Transplant 2016 Oct;22(10):1893-1899       36 Citations
1Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration. (Dwivedi H, Singh SK, Chauhan BS, Gunjan S, Tripathi R) Parasitology 2016 Oct;143(12):1557-68       14 Citations
2Donor and recipient sex in allogeneic stem cell transplantation: what really matters. (Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, Perales MA, Armand P, Eapen M) Haematologica 2016 Oct;101(10):1260-1266       65 Citations
1Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity. (Weaver AN, Burch MB, Cooper TS, Della Manna DL, Wei S, Ojesina AI, Rosenthal EL, Yang ES) Mol Cancer Res 2016 Sep;14(9):883-91       34 Citations
2Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. (Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JH, Auletta J, Komanduri KV, Lindemans C, Riches ML) Biol Blood Marrow Transplant 2016 Sep;22(9):1636-1645       69 Citations
3Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. (D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P) Br J Haematol 2017 Sep;178(5):816-819       2 Citations
1The inpatient burden of psoriasis in the United States. (Hsu DY, Gordon K, Silverberg JI) J Am Acad Dermatol 2016 Jul;75(1):33-41       24 Citations
1BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System. (Janku F, Huang HJ, Claes B, Falchook GS, Fu S, Hong D, Ramzanali NM, Nitti G, Cabrilo G, Tsimberidou AM, Naing A, Piha-Paul SA, Wheler JJ, Karp DD, Holley VR, Zinner RG, Subbiah V, Luthra R, Kopetz S, Overman MJ, Kee BK, Patel S, Devogelaere B, Sablon E, Maertens G, Mills GB, Kurzrock R, Meric-Bernstam F) Mol Cancer Ther 2016 Jun;15(6):1397-404       75 Citations
9Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. (Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN) Clin Lymphoma Myeloma Leuk 2016 Jul;16(7):379-86       22 Citations
1Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. (Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Guan W, Haagenson M, Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan B) Biol Blood Marrow Transplant 2016 Aug;22(8):1531-1532       6 Citations
1Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. (O'Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF) Clin Genitourin Cancer 2016 Dec;14(6):511-517       5 Citations
1Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer. (Felder TM, Do DP, Lu ZK, Lal LS, Heiney SP, Bennett CL) Breast Cancer Res Treat 2016 May;157(1):193-200       5 Citations
2Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. (Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Aug;22(8):1440-1448       43 Citations
1Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. (Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek ME) Respir Med 2016 May;114:53-60       53 Citations
3The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children. (Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM) Biol Blood Marrow Transplant 2016 Aug;22(8):1460-1466       6 Citations
2Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. (Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M, Eurocord, Cord Blood Committee Cellular Therapy Immunobiology Working Party of the European Group for Blood and Marrow Transplantation, Netcord, and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2016 Jul;22(7):1284-1289       29 Citations
2Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? (Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK) J Surg Oncol 2016 Jun;113(7):823-7       16 Citations
4Breast and Colorectal Cancer Survival Disparities in Southeastern Wisconsin. (Beyer KM, Zhou Y, Matthews K, Hoormann K, Bemanian A, Laud PW, Nattinger AB) WMJ 2016 Feb;115(1):17-21       20 Citations
1Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. (Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr) N Engl J Med 2016 Apr 07;374(14):1344-55       857 Citations
2Impact of early CMV reactivation in cord blood stem cell recipients in the current era. (Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani B, Waller EK, Wingard J, Auletta JJ, Lindemans CA, Boeckh M, Riches ML) Bone Marrow Transplant 2016 Aug;51(8):1113-20       38 Citations
1Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. (Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK) Biol Blood Marrow Transplant 2016 Jul;22(7):1197-1205       18 Citations
1Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia. (Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R) Biol Blood Marrow Transplant 2016 Jul;22(7):1257-1263       59 Citations
3Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis. (Chaudhury S, Sparapani R, Hu ZH, Nishihori T, Abdel-Azim H, Malone A, Olsson R, Hamadani M, Daly A, Bacher U, Wirk BM, Kamble RT, Gale RP, Wood WA, Hale G, Wiernik PH, Hashmi SK, Marks D, Ustun C, Munker R, Savani BN, Alyea E, Popat U, Sobecks R, Kalaycio M, Maziarz R, Hijiya N, Saber W) Biol Blood Marrow Transplant 2016 Jun;22(6):1056-1064       30 Citations
2Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. (Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL) N Engl J Med 2016 Mar 10;374(10):940-50       305 Citations
1Outcomes and Use of Laparoscopic Versus Open Gastric Resection. (Higgins RM, Kubasiak JC, Jacobson RA, Janssen I, Myers JA, Millikan KW, Deziel DJ, Luu MB) JSLS 2015;19(4)       10 Citations
1Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis. (Wang Y, Jadhav RR, Liu J, Wilson D, Chen Y, Thompson IM, Troyer DA, Hernandez J, Shi H, Leach RJ, Huang TH, Jin VX) Sci Rep 2016 Feb 29;6:22051       18 Citations
1VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer. (Xie W, Liu F, Wang Y, Ren X, Wang T, Chen Z, Tang M, Sun F, Li Z, Wang M, Zhang J) Oncotarget 2016 Mar 29;7(13):16445-61       18 Citations
1PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence. (Singh P, Rao RN, Reddy JR, Prasad RB, Kotturu SK, Ghosh S, Mukhopadhyay S) Sci Rep 2016 Feb 23;6:21624       98 Citations
3Nonparametric survival analysis using Bayesian Additive Regression Trees (BART). (Sparapani RA, Logan BR, McCulloch RE, Laud PW) Stat Med 2016 Jul 20;35(16):2741-53       116 Citations
1Outcomes after resection of cortisol-secreting adrenocortical carcinoma. (Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Am J Surg 2016 Jun;211(6):1106-13       45 Citations
1Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MRM, Champlin RE, Ciurea SO) Biol Blood Marrow Transplant 2016 Apr;22(4):594-604       9 Citations
1Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study. (Undurraga Perl VJ, Leroux B, Cook MR, Watson J, Fair K, Martin DT, Kerby JD, Williams C, Inaba K, Wade CE, Cotton BA, Del Junco DJ, Fox EE, Scalea TM, Tilley BC, Holcomb JB, Schreiber MA, PROPPR Study Group) J Trauma Acute Care Surg 2016 Apr;80(4):568-74; discussion 574-5       24 Citations
1A Review of Pediatric Chronic Kidney Disease. (Kaspar CD, Bholah R, Bunchman TE) Blood Purif 2016;41(1-3):211-7       89 Citations
3Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. (Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W) Biol Blood Marrow Transplant 2016 Apr;22(4):744-751       46 Citations
2New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation. (D'Souza A, Huang J, Hari P) Biol Blood Marrow Transplant 2016 Apr;22(4):768-770       6 Citations
290Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study. (Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R) J Nucl Med 2016 May;57(5):665-71       84 Citations
1Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. (Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, Hematti P, Denu JM) J Biol Chem 2016 Feb 12;291(7):3268-79       76 Citations
1Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors. (Arrieta-Bolaños E, Mayor NP, Marsh SG, Madrigal JA, Apperley JF, Kirkland K, Mackinnon S, Marks DI, McQuaker G, Perry J, Potter MN, Russell NH, Thomson K, Shaw BE) Haematologica 2016 Mar;101(3):382-90       7 Citations
4Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900       105 Citations
2The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7       286 Citations
1Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer. (Eng KH, Hanlon BM, Bradley WH, Szender JB) Gynecol Oncol 2015 Nov;139(2):228-35       23 Citations
3Location of brain tumor intersecting white matter tracts predicts patient prognosis. (Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D, Connelly J, Schmainda KM, LaViolette PS) J Neurooncol 2015 Nov;125(2):393-400       30 Citations
2Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups. (Deeg HJ, Bredeson C, Farnia S, Ballen K, Gupta V, Mesa RA, Popat U, Hari P, Saber W, Seftel M, Tamari R, Petersdorf EW) Biol Blood Marrow Transplant 2015 Nov;21(11):1883-7       39 Citations
3Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research. (Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL) Biol Blood Marrow Transplant 2015 Dec;21(12):2154-2159       30 Citations
2In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. (Ponce DM, Eapen M, Sparapani R, O'Brien TA, Chan KW, Chen J, Craddock J, Schultz KR, Wagner JE, Perales MA, Barker JN) Biol Blood Marrow Transplant 2015 Dec;21(12):2173-2179       18 Citations
2Factors associated with patients transferred from undesignated trauma centers to trauma centers. (Tarima S, Ertl A, Groner JI, Cassidy LD) J Trauma Acute Care Surg 2015 Sep;79(3):378-85       18 Citations
1Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. (Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH) Oncogene 2016 May 05;35(18):2379-89       17 Citations
4Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors. (Klyuchnikov E, Bacher U, Kröger NM, Hari PN, Ahn KW, Carreras J, Bachanova V, Bashey A, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Hertzberg MS, Holmberg LA, Kharfan-Dabaja MA, Klein A, Ku GH, Laport GG, Lazarus HM, Miller AM, Mussetti A, Olsson RF, Slavin S, Usmani SZ, Vij R, Wood WA, Maloney DG, Sureda AM, Smith SM, Hamadani M) Biol Blood Marrow Transplant 2015 Dec;21(12):2091-2099       51 Citations
1Comparison of in-hospital and longer-term outcomes of hybrid and Norwood stage 1 palliation of hypoplastic left heart syndrome. (Malik S, Bird TM, Jaquiss RD, Morrow WR, Robbins JM) J Thorac Cardiovasc Surg 2015 Sep;150(3):474-80.e2       33 Citations
1Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. (Vaughn JE, Sorror ML, Storer BE, Chauncey TR, Pulsipher MA, Maziarz RT, Maris MB, Hari P, Laport GG, Franke GN, Agura ED, Langston AA, Rezvani AR, Storb R, Sandmaier BM, Maloney DG) Cancer 2015 Oct 15;121(20):3709-16       35 Citations
1Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients. (Stephens DM, Ruppert AS, Weirda WG, Jones JA, Woyach JA, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Tam C, O'Brien S, Keating MJ, Muthusamy N, Abruzzo LV, Heerema NA, Byrd JC) Am J Hematol 2015 Nov;90(11):967-9       2 Citations
5Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. (Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ) HPB (Oxford) 2015 Aug;17(8):707-12       13 Citations
1Measuring selective constraint on fertility in human life histories. (Jones JH, Tuljapurkar S) Proc Natl Acad Sci U S A 2015 Jul 21;112(29):8982-6       15 Citations
1Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. (Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB) Cancer 2015 Oct 01;121(19):3491-8       212 Citations
2Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. (Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN, Burns LJ, Dalal JD, Freytes CO, Gupta V, Inamoto Y, Lazarus HM, LeMaistre CF, Steinberg A, Szwajcer D, Wingard JR, Wirk B, Wood WA, Joffe S, Hahn TE, Loberiza FR, Anasetti C, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1815-22       12 Citations
1The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab. (Busaidy NL, LoRusso P, Lawhorn K, Hess KR, Habra MA, Fu S, Hong DS, Chen HX, Doyle LA, Kurzrock R, Naing A) Oncologist 2015 Jul;20(7):737-41       13 Citations
1HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease. (Li J, Heinrichs J, Haarberg K, Semple K, Veerapathran A, Liu C, Anasetti C, Yu XZ) J Immunol 2015 Jul 15;195(2):717-25       24 Citations
3Lower Leg Injury Reference Values and Risk Curves from Survival Analysis for Male and Female Dummies: Meta-analysis of Postmortem Human Subject Tests. (Yoganandan N, Arun MW, Pintar FA, Banerjee A) Traffic Inj Prev 2015;16 Suppl 1:S100-7       21 Citations
1Hematopoietic stem cell transplantation for infantile osteopetrosis. (Orchard PJ, Fasth AL, Le Rademacher J, He W, Boelens JJ, Horwitz EM, Al-Seraihy A, Ayas M, Bonfim CM, Boulad F, Lund T, Buchbinder DK, Kapoor N, O'Brien TA, Perez MA, Veys PA, Eapen M) Blood 2015 Jul 09;126(2):270-6       91 Citations
1Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. (Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Pérez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, Lund TC, Leung WH, Davies SM) Biol Blood Marrow Transplant 2015 Jul;21(7):1273-7       22 Citations
1The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. (Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL) Biol Blood Marrow Transplant 2015 Jul;21(7):1251-7       15 Citations
1Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. (Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth I) Chest 2015 Sep;148(3):692-700       47 Citations
1Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites. (Rateb ME, Yang D, Vodanovic-Jankovic S, Yu Z, Kron MA, Shen B) J Antibiot (Tokyo) 2015 Aug;68(8):540-2       12 Citations
1Biventricular Berlin Heart EXCOR pediatric use across the united states. (Zafar F, Jefferies JL, Tjossem CJ, Bryant R 3rd, Jaquiss RD, Wearden PD, Rosenthal DN, Cabrera AG, Rossano JW, Humpl T, Morales DL) Ann Thorac Surg 2015 Apr;99(4):1328-34       54 Citations
1Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung. (Abedin S, Yanik GA, Braun T, Pawarode A, Magenau J, Goldstein SC, Levine JE, Kitko CL, Couriel DR) Biol Blood Marrow Transplant 2015 Jun;21(6):1127-31       47 Citations
3Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053       139 Citations
1Gustatory and metabolic perception of nutrient stress in Drosophila. (Linford NJ, Ro J, Chung BY, Pletcher SD) Proc Natl Acad Sci U S A 2015 Feb 24;112(8):2587-92       31 Citations
1Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. (Roberts KJ, Sutton AJ, Prasad KR, Toogood GJ, Lodge JP) Br J Surg 2015 Mar;102(4):388-98       12 Citations
1Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database. (Shukla ME, Yu C, Reddy CA, Stephans KL, Klein EA, Abdel-Wahab M, Ciezki J, Tendulkar RD) Clin Genitourin Cancer 2015 Feb;13(1):17-21       17 Citations
3Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9       48 Citations
1MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. (Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE) Cell Stem Cell 2014 Dec 04;15(6):762-74       155 Citations
1Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation. (Radhakrishnan SV, Palaniyandi S, Mueller G, Miklos S, Hager M, Spacenko E, Karlsson FJ, Huber E, Kittan NA, Hildebrandt GC) Biol Blood Marrow Transplant 2015 Jan;21(1):30-8       16 Citations
1A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. (Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C) Surgery 2014 Dec;156(6):1378-85; discussion 1385-6       39 Citations
1Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis. (Police RL, Trask PC, Wang J, Olivares R, Khan S, Abbe A, Colosia A, Njue A, Sherrill B, Ruiz-Soto R, Kaye JA, Hamadani M) Clin Lymphoma Myeloma Leuk 2015 Apr;15(4):199-207       2 Citations
2Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23       32 Citations
1Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. (Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN) Biol Blood Marrow Transplant 2015 Feb;21(2):335-41       64 Citations
1Is central lymph node dissection necessary for parathyroid carcinoma? (Hsu KT, Sippel RS, Chen H, Schneider DF) Surgery 2014 Dec;156(6):1336-41; discussion 1341       75 Citations
1Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. (Kershaw KN, Osypuk TL, Do DP, De Chavez PJ, Diez Roux AV) Circulation 2015 Jan 13;131(2):141-8       178 Citations
5Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR) Biol Blood Marrow Transplant 2015 Feb;21(2):266-74       373 Citations
1Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation. (Kornblit B, Enevold C, Wang T, Spellman S, Haagenson M, Lee SJ, Müller K) Biol Blood Marrow Transplant 2015 Feb;21(2):259-65       5 Citations
1Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma. (Hackett CS, Quigley DA, Wong RA, Chen J, Cheng C, Song YK, Wei JS, Pawlikowska L, Bao Y, Goldenberg DD, Nguyen K, Gustafson WC, Rallapalli SK, Cho YJ, Cook JM, Kozlov S, Mao JH, Van Dyke T, Kwok PY, Khan J, Balmain A, Fan Q, Weiss WA) Cell Rep 2014 Nov 06;9(3):1034-46       29 Citations
2Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. (Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML) Biol Blood Marrow Transplant 2015 Jan;21(1):151-8       54 Citations
3Optimized lower leg injury probability curves from postmortem human subject tests under axial impacts. (Yoganandan N, Arun MW, Pintar FA, Szabo A) Traffic Inj Prev 2014;15 Suppl 1(0 1):S151-6       34 Citations
2Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. (Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE) Biol Blood Marrow Transplant 2015 Jan;21(1):55-9       31 Citations
3Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. (Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S) J Gastrointest Surg 2014 Nov;18(11):2016-25       44 Citations
1The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. (Nagle SJ, Chong EA, Chekol S, Shah NN, Nasta SD, Glatstein E, Plastaras JP, Torigian DA, Schuster SJ, Svoboda J) Cancer Med 2015 Jan;4(1):7-15       20 Citations
1Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia. (Malhotra P, Bodh V, Guru Murthy GS, Datta AK, Varma N, Varma S) Hematology 2015 May;20(4):239-44       11 Citations
3Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8       12 Citations
2Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. (Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duffner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML 4th, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR) JAMA 2014 Aug 20;312(7):729-38       600 Citations
1MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors. (Jardim DL, de Melo Gagliato D, Falchook G, Zinner R, Wheler JJ, Janku F, Subbiah V, Piha-Paul SA, Fu S, Tannir N, Corn P, Tang C, Hess K, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS) Clin Genitourin Cancer 2015 Feb;13(1):e19-26       17 Citations
1Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources. (Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS) Biol Blood Marrow Transplant 2014 Nov;20(11):1819-27       42 Citations
1Group sequential tests for long-term survival comparisons. (Logan BR, Mo S) Lifetime Data Anal 2015 Apr;21(2):218-40       4 Citations
1Apples to apples or apples to oranges? International variation in reporting of process and outcome of care for out-of-hospital cardiac arrest. (Nishiyama C, Brown SP, May S, Iwami T, Koster RW, Beesems SG, Kuisma M, Salo A, Jacobs I, Finn J, Sterz F, Nürnberger A, Smith K, Morrison L, Olasveengen TM, Callaway CW, Shin SD, Gräsner JT, Daya M, Ma MH, Herlitz J, Strömsöe A, Aufderheide TP, Masterson S, Wang H, Christenson J, Stiell I, Davis D, Huszti E, Nichol G) Resuscitation 2014 Nov;85(11):1599-609       67 Citations
1Characteristics and survival of patients with advanced cancer and p53 mutations. (Said R, Ye Y, Hong DS, Janku F, Fu S, Naing A, Wheler JJ, Kurzrock R, Thomas C, Palmer GA, Hess KR, Aldape K, Tsimberidou AM) Oncotarget 2014 Jun 15;5(11):3871-9       11 Citations
1Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. (Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C) J Clin Oncol 2014 Aug 01;32(22):2365-72       77 Citations
1Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. (Ruggeri A, Labopin M, Sormani MP, Sanz G, Sanz J, Volt F, Michel G, Locatelli F, Diaz De Heredia C, O'Brien T, Arcese W, Iori AP, Querol S, Kogler G, Lecchi L, Pouthier F, Garnier F, Navarrete C, Baudoux E, Fernandes J, Kenzey C, Eapen M, Gluckman E, Rocha V, Saccardi R, Eurocord, Cord Blood Committee EBMT, Netcord) Haematologica 2014 Sep;99(9):1509-15       48 Citations
3Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72       14 Citations
1Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Discekici-Harris M, Mittal BB) Head Neck 2015 Nov;37(11):1575-82       41 Citations
2Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1530-6       75 Citations
1Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. (Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M) Biol Blood Marrow Transplant 2014 Sep;20(9):1418-25       42 Citations
1Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. (Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A, Fuchs EJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1485-92       43 Citations
1Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III). (Jaccard A, Comenzo RL, Hari P, Hawkins PN, Roussel M, Morel P, Macro M, Pellegrin JL, Lazaro E, Mohty D, Mercie P, Decaux O, Gillmore J, Lavergne D, Bridoux F, Wechalekar AD, Venner CP) Haematologica 2014 Sep;99(9):1479-85       113 Citations
73-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25       30 Citations
1Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. (Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):360-9       11 Citations
1Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. (El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J, Flowers M, Weisdorf D, Pavletic S, Jaglowski S, Jagasia M, Lee SJ, Chen YB) Biol Blood Marrow Transplant 2014 Sep;20(9):1341-8       46 Citations
2Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. (Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK) Eur J Cancer 2014 Jul;50(10):1747-1757       78 Citations
1Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes. (Mukkamala A, Allam CL, Ellison JS, Hafez KS, Miller DC, Montgomery JS, Weizer AZ, Wolf JS Jr) Urology 2014 Jun;83(6):1294-9       48 Citations
3Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. (McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ) Biol Blood Marrow Transplant 2014 Jul;20(7):960-8       33 Citations
2Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. (Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W) Biol Blood Marrow Transplant 2014 Jul;20(7):951-9       33 Citations
1CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. (Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer Res 2014 May 15;74(10):2677-87       35 Citations
1Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. (Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG) World J Surg 2014 Jun;38(6):1318-27       51 Citations
1Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia. (Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, Lemaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS) Biol Blood Marrow Transplant 2014 Jun;20(6):829-36       40 Citations
2CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400       78 Citations
1Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82       64 Citations
2Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7       22 Citations
1Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML. (Anthias C, Dignan FL, Morilla R, Morilla A, Ethell ME, Potter MN, Shaw BE) Bone Marrow Transplant 2014 May;49(5):679-83       76 Citations
1Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. (Wong HR, Weiss SL, Giuliano JS Jr, Wainwright MS, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, Hall M, Freishtat RJ, Sen A, Meyer K, Checchia PA, Shanley TP, Nowak J, Quasney M, Chopra A, Fitzgerald JC, Gedeit R, Banschbach S, Beckman E, Lahni P, Hart K, Lindsell CJ) PLoS One 2014;9(1):e86242       71 Citations
1Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. (Duléry R, Mohty M, Duhamel A, Robin M, Beguin Y, Michallet M, Vigouroux S, Lioure B, Garnier A, El Cheikh J, Bulabois CE, Huynh A, Bay JO, Daguindau E, Ceballos P, Clément L, Dauriac C, Maillard N, Legrand F, Cornillon J, Guillerm G, François S, Lapusan S, Chevallier P, Damaj G, Yakoub-Agha I) Biol Blood Marrow Transplant 2014 May;20(5):646-54       23 Citations
1Fulminant Clostridium difficile colitis: prospective development of a risk scoring system. (van der Wilden GM, Chang Y, Cropano C, Subramanian M, Schipper IB, Yeh DD, King DR, de Moya MA, Fagenholz PJ, Velmahos GC) J Trauma Acute Care Surg 2014 Feb;76(2):424-30       40 Citations
1Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. (Schmainda KM, Prah M, Connelly J, Rand SD, Hoffman RG, Mueller W, Malkin MG) Neuro Oncol 2014 Jun;16(6):880-8       107 Citations
1Gunshot wounds and blast injuries to the face are associated with significant morbidity and mortality: results of an 11-year multi-institutional study of 720 patients. (Shackford SR, Kahl JE, Calvo RY, Kozar RA, Haugen CE, Kaups KL, Willey M, Tibbs BM, Mutto SM, Rizzo AG, Lormel CS, Shackford MC, Burlew CC, Moore EE, Cogbill TH, Kallies KJ, Haan JM, Ward J) J Trauma Acute Care Surg 2014 Feb;76(2):347-52       34 Citations
1Antithymocyte globulin in reduced-intensity conditioning allografting: is the benefit simply in the eyes of the transplanter? (Hamadani M) Biol Blood Marrow Transplant 2014 Mar;20(3):292-4       2 Citations
1Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation. (Rauenzahn S, Truong Q, Cumpston A, Goff L, Leadmon S, Evans K, Zhang J, Wen S, Craig M, Hamadani M, Kanate AS) Biol Blood Marrow Transplant 2014 Mar;20(3):415-20       16 Citations
1Pseudo-value approach for comparing survival medians for dependent data. (Ahn KW, Mendolia F) Stat Med 2014 Apr 30;33(9):1531-8       7 Citations
4Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. (Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN) Biol Blood Marrow Transplant 2014 Mar;20(3):402-408.e1       93 Citations
2Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? (Sabloff M, Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP, Saber W) Biol Blood Marrow Transplant 2014 Mar;20(3):421-4       14 Citations
1Introduction: Malignant primary bone tumors in children and young adults. (Kent PM, Ording J, Dabrowski E, Shah K, Trafton L) Curr Probl Cancer 2013;37(4):160-6       1 Citation
1Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR. (Anderson ML, Peterson ED, Peng SA, Wang TY, Ohman EM, Bhatt DL, Saucedo JF, Roe MT) Circ Cardiovasc Qual Outcomes 2013 Nov;6(6):708-15       115 Citations
1EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. (Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S) Bone Marrow Transplant 2014 Feb;49(2):280-6       77 Citations
3Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR) Biol Blood Marrow Transplant 2014 Feb;20(2):202-8       35 Citations
1Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease. (Hamadani M, Gibson LF, Remick SC, Wen S, Petros W, Tse W, Brundage KM, Vos JA, Cumpston A, Bunner P, Craig MD) J Clin Oncol 2013 Dec 10;31(35):4416-23       32 Citations
4Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. (Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W) Biol Blood Marrow Transplant 2014 Jan;20(1):89-97       123 Citations
1Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. (Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ) J Exp Med 2013 Oct 21;210(11):2223-37       131 Citations
2Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. (Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC) Blood 2013 Dec 05;122(24):3871-8       127 Citations
1Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis. (Kharfan-Dabaja MA, Hamadani M, Reljic T, Pyngolil R, Komrokji RS, Lancet JE, Fernandez HF, Djulbegovic B, Kumar A) Br J Haematol 2013 Nov;163(3):315-25       33 Citations
4A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position. (Bergom C, Prior P, Kainz K, Morrow NV, Ahunbay EE, Walker A, Allen Li X, White J) Radiother Oncol 2013 Aug;108(2):215-9       19 Citations
1ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. (Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Am J Clin Oncol 2013 Aug;36(4):415-22       17 Citations
1Body composition and survival in the early clinical trials setting. (Veasey Rodrigues H, Baracos VE, Wheler JJ, Parsons HA, Hong DS, Naing A, Fu S, Falchoock G, Tsimberidou AM, Piha-Paul S, Chisholm G, Kurzrock R) Eur J Cancer 2013 Oct;49(15):3068-75       35 Citations
4Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). (Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM) Blood 2013 Sep 12;122(11):1974-82       91 Citations
2Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. (Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, Maharaj D, Munker R, Phillips GL, Rizzieri DA, Rowlings PA, Saber W, Satwani P, Waller EK, Maloney DG, Montoto S, Laport GG, Vose JM, Lazarus HM, Hari PN) Br J Haematol 2013 Sep;162(5):648-56       25 Citations
1The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. (Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, Goldman F, Kapoor N, Small T, Smith A, Chan KW, Cuvelier G, Heimall J, Knutsen A, Loechelt B, Moore T, Buckley RH) J Clin Immunol 2013 Oct;33(7):1156-64       93 Citations
1The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9       35 Citations
1Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression. (Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, Farfara D, Kingery ND, Weiner HL, El Khoury J) Nat Commun 2013;4:2030       173 Citations
1Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. (Benson AB 3rd, Geschwind JF, Mulcahy MF, Rilling W, Siskin G, Wiseman G, Cunningham J, Houghton B, Ross M, Memon K, Andrews J, Fleming CJ, Herman J, Nimeiri H, Lewandowski RJ, Salem R) Eur J Cancer 2013 Oct;49(15):3122-30       72 Citations
1Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses. (Wheler J, Hong D, Swisher SG, Falchook G, Tsimberidou AM, Helgason T, Naing A, Stephen B, Janku F, Stephens PJ, Yelensky R, Kurzrock R) Oncotarget 2013 Jun;4(6):890-8       39 Citations
1Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. (Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA) Biol Blood Marrow Transplant 2013 Aug;19(8):1238-43       104 Citations
1Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. (Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski JL, Hale GA, Isola LM, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS) J Clin Oncol 2013 Jul 01;31(19):2437-49       218 Citations
1Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor. (Shamim Z, Spellman S, Haagenson M, Wang T, Lee SJ, Ryder LP, Müller K) Scand J Immunol 2013 Aug;78(2):214-20       21 Citations
1Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. (Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group) Br J Haematol 2013 Aug;162(3):376-82       205 Citations
1A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. (Ellison TA, Wolfgang CL, Shi C, Cameron JL, Murakami P, Mun LJ, Singhi AD, Cornish TC, Olino K, Meriden Z, Choti M, Diaz LA, Pawlik TM, Schulick RD, Hruban RH, Edil BH) Ann Surg 2014 Feb;259(2):204-12    
1Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience. (Lu Y, Jansen JF, Stambuk HE, Gupta G, Lee N, Gonen M, Moreira A, Mazaheri Y, Patel SG, Deasy JO, Shah JP, Shukla-Dave A) J Comput Assist Tomogr 2013;37(3):346-52       45 Citations
1Enhancing the protective immune response against botulism. (Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT) Infect Immun 2013 Jul;81(7):2638-44       23 Citations
1Home monitoring program reduces interstage mortality after the modified Norwood procedure. (Siehr SL, Norris JK, Bushnell JA, Ramamoorthy C, Reddy VM, Hanley FL, Wright GE) J Thorac Cardiovasc Surg 2014 Feb;147(2):718-23.e1       68 Citations
1Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. (McCarthy PL Jr, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, Isola L, Lazarus HM, Lee SJ, Lemaistre CF, Loberiza F, Maziarz RT, Rizzo JD, Joffe S, Parsons S, Majhail NS) Biol Blood Marrow Transplant 2013 Jul;19(7):1116-23       94 Citations
1Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ) Biol Blood Marrow Transplant 2013 Jul;19(7):1102-8       16 Citations
1Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. (D'Souza A, Theis J, Quint P, Kyle R, Gertz M, Zeldenrust S, Vrana J, Dogan A, Dispenzieri A) Am J Hematol 2013 Jul;88(7):577-80       17 Citations
1Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia. (Burke MJ, Wagner JE, Cao Q, Ustun C, Verneris MR) Biol Blood Marrow Transplant 2013 Jul;19(7):1021-5       25 Citations
2Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration. (Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM) Biol Blood Marrow Transplant 2013 Jun;19(6):858-9       2 Citations
1Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, LeRademacher J, Thakar M, Deeg HJ, Al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pasquini R, Macmillan ML, George B, Copelan EA, Wirk B, Al Jefri A, Fasth AL, Guinan EC, Horn BN, Lewis VA, Slavin S, Stepensky P, Bierings M, Gale RP) J Clin Oncol 2013 May 01;31(13):1669-76       67 Citations
1Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. (Bar M, Sandmaier BM, Inamoto Y, Bruno B, Hari P, Chauncey T, Martin PJ, Storb R, Maloney DG, Storer B, Flowers ME) Biol Blood Marrow Transplant 2013 Jun;19(6):949-57       83 Citations
1Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Biol Blood Marrow Transplant 2013 Jun;19(6):893-7       42 Citations
1Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. (Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Mahfouz RA, Hamadani M) Biol Blood Marrow Transplant 2013 Jul;19(7):1006-12       73 Citations
1Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. (El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) Hepatobiliary Pancreat Dis Int 2013 Feb;12(1):34-41    
1Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(®)) System. (Zosel A, Bartelson BB, Bailey E, Lowenstein S, Dart R) J Am Acad Child Adolesc Psychiatry 2013 Feb;52(2):196-204.e2       84 Citations
1The natural history of vertebral artery origin stenosis. (Thompson MC, Issa MA, Lazzaro MA, Zaidat OO) J Stroke Cerebrovasc Dis 2014 Jan;23(1):e1-4       20 Citations
4Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. (Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM) Biol Blood Marrow Transplant 2013 Apr;19(4):625-31       76 Citations
1Management of primary hepatopancreatobiliary small cell carcinoma. (Groeschl RT, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2013 Jun;107(7):692-5       10 Citations
1Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. (Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2013 Mar;19(3):481-5       5 Citations
1The mathematics of morality for neonatal resuscitation. (Meadow W, Lagatta J, Andrews B, Lantos J) Clin Perinatol 2012 Dec;39(4):941-56       32 Citations
1Tie2(+) bone marrow endothelial cells regulate hematopoietic stem cell regeneration following radiation injury. (Doan PL, Russell JL, Himburg HA, Helms K, Harris JR, Lucas J, Holshausen KC, Meadows SK, Daher P, Jeffords LB, Chao NJ, Kirsch DG, Chute JP) Stem Cells 2013 Feb;31(2):327-37       63 Citations
1Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. (Marsh RA, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH) Blood 2013 Feb 07;121(6):877-83       134 Citations
1Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. (Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H) Clin Cancer Res 2012 Oct 01;18(19):5507-14       54 Citations
1Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research. (Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS) Biol Blood Marrow Transplant 2012 Dec;18(12):1776-84       33 Citations
1A multicenter prospective analysis of pediatric trauma activation criteria routinely used in addition to the six criteria of the American College of Surgeons. (Falcone RA Jr, Haas L, King E, Moody S, Crow J, Moss A, Gaines B, McKenna C, Gourlay DM, Werner C, Meagher DP Jr, Schwing L, Garcia N, Brown D, Groner JI, Haley K, Deross A, Cizmar L, Armola R) J Trauma Acute Care Surg 2012 Aug;73(2):377-84; discussion 384       43 Citations
1Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia. (Jaglowski SM, Ruppert AS, Heerema NA, Bingman A, Flynn JM, Grever MR, Jones JA, Elder P, Devine SM, Byrd JC, Andritsos LA) Br J Haematol 2012 Oct;159(1):82-7       54 Citations
1Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack. (Depta JP, Fowler J, Novak E, Katzan I, Bakdash S, Kottke-Marchant K, Bhatt DL) Stroke 2012 Sep;43(9):2376-81       48 Citations
1Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome. (Pardanani A, D'Souza A, Knudson RA, Hanson CA, Ketterling RP, Tefferi A) Leukemia 2012 Nov;26(11):2439-41       52 Citations
1MprA and DosR coregulate a Mycobacterium tuberculosis virulence operon encoding Rv1813c and Rv1812c. (Bretl DJ, He H, Demetriadou C, White MJ, Penoske RM, Salzman NH, Zahrt TC) Infect Immun 2012 Sep;80(9):3018-33       40 Citations
1Allogeneic transplantation for aplastic anemia. (Eapen M) Hematology 2012 Apr;17 Suppl 1:S15-7       5 Citations
1Effect of light-cure initiation time on polymerization efficiency and orthodontic bond strength with a resin-modified glass-ionomer. (Thomas JT, Roberts HW, Diaz L, Bradley TG, Berzins DW) Orthod Craniofac Res 2012 May;15(2):124-34       7 Citations
1Primary hepatic leiomyosarcoma in adults: analysis of prognostic factors. (Chi M, Dudek AZ, Wind KP) Onkologie 2012;35(4):210-4       20 Citations
1Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. (Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE) JAMA 2012 May 09;307(18):1925-33       191 Citations
4Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. (Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W) Biol Blood Marrow Transplant 2012 Sep;18(9):1446-54       18 Citations
2Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. (Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA, Gross TG, Horwitz M, Horwitz E, Kapoor N, Kurtzberg J, Majhail N, Ringden O, Szabolcs P, Veys P, Baker KS) Biol Blood Marrow Transplant 2012 Sep;18(9):1438-45       41 Citations
3HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. (Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani BN, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano-Ispizua A, Cutler C, Flowers ME, Spellman SR) Biol Blood Marrow Transplant 2012 Aug;18(8):1302-8       12 Citations
1Which score system can best predict recipient outcomes after living donor liver transplantation? (Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK) Transplant Proc 2012 Mar;44(2):393-5       16 Citations
3Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10       53 Citations
2Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72       172 Citations
1Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. (Patel Y, Depta JP, Novak E, Yeung M, Lavine K, Banerjee S, Lin CH, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J) Am J Cardiol 2012 Apr 01;109(7):960-5       38 Citations
1Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. (Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Gaynor JW, Jacobs JP) Pediatrics 2012 Feb;129(2):e385-91       100 Citations
1Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. (Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW) Clin Cancer Res 2012 Mar 01;18(5):1464-71       98 Citations
1Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. (Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R) PLoS One 2012;7(1):e29330       92 Citations
2Hypoplastic left heart syndrome: current considerations and expectations. (Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafañe J, Bhatt AB, Peng LF, Johnson BA, Marsden AL, Daniels CJ, Rudd NA, Caldarone CA, Mussatto KA, Morales DL, Ivy DD, Gaynor JW, Tweddell JS, Deal BJ, Furck AK, Rosenthal GL, Ohye RG, Ghanayem NS, Cheatham JP, Tworetzky W, Martin GR) J Am Coll Cardiol 2012 Jan 03;59(1 Suppl):S1-42       450 Citations
1Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. (Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola L, Perales MA, Seftel M, Vose JM, Miller AM, Gibson J, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, Martino R, Marks DI, Hale GA, Smith SM, Schouten HC, Slavin S, Klumpp TR, Lazarus HM, van Besien K, Hari PN) Biol Blood Marrow Transplant 2012 Aug;18(8):1255-64       23 Citations
1Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 01;118(15):3801-11       60 Citations
1Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. (Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT),, Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)) Biol Blood Marrow Transplant 2012 Mar;18(3):348-71       308 Citations
1Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. (Hale GA, Shrestha S, Le-Rademacher J, Burns LJ, Gibson J, Inwards DJ, Freytes CO, Bolwell BJ, Hsu JW, Slavin S, Isola L, Rizzieri DA, Gale RP, Laport GG, Montoto S, Lazarus HM, Hari PN) Biol Blood Marrow Transplant 2012 Jul;18(7):1036-1043.e1       15 Citations
1Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. (Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JP) J Am Coll Surg 2012 Feb;214(2):174-83       48 Citations
1Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia. (Honebrink T, Dayton V, Burke MJ, Larsen K, Cao Q, Brunstein C, Weisdorf D, Miller JS, Wagner JE, Verneris MR) Biol Blood Marrow Transplant 2012 Jun;18(6):930-6       23 Citations
1Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. (Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P, Pulsipher MA, Bethge W, Sahebi F, Bruno B, Maris MB, Yeager A, Petersen FB, Vindeløv L, McSweeney PA, Hübel K, Mielcarek M, Georges GE, Niederwieser D, Blume KG, Maloney DG, Storb R) JAMA 2011 Nov 02;306(17):1874-83       270 Citations
1BRAF mutations in advanced cancers: clinical characteristics and outcomes. (El-Osta H, Falchook G, Tsimberidou A, Hong D, Naing A, Kim K, Wen S, Janku F, Kurzrock R) PLoS One 2011;6(10):e25806       83 Citations
1The complex relationship between center volume and outcome in patients undergoing the Norwood operation. (Pasquali SK, Jacobs JP, He X, Hornik CP, Jaquiss RD, Jacobs ML, O'Brien SM, Peterson ED, Li JS) Ann Thorac Surg 2012 May;93(5):1556-62       93 Citations
1Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. (Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman SR, Weisdorf DJ, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Oct 20;118(16):4472-9       44 Citations
4Nationwide trends of severe sepsis in the 21st century (2000-2007). (Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J, Jacobs E, Nanchal R, Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators) Chest 2011 Nov;140(5):1223-1231       528 Citations
1Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program. (Fu S, Hong DS, Naing A, Wheler J, Falchook G, Wen S, Howard A, Barber D, Nates J, Price K, Kurzrock R) J Clin Oncol 2011 Sep 10;29(26):3547-52       26 Citations
1Subunit vaccine efficacy against Botulinum neurotoxin subtypes. (Henkel JS, Tepp WH, Przedpelski A, Fritz RB, Johnson EA, Barbieri JT) Vaccine 2011 Oct 13;29(44):7688-95       13 Citations
1Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. (Dunn TB, Noreen H, Gillingham K, Maurer D, Ozturk OG, Pruett TL, Bray RA, Gebel HM, Matas AJ) Am J Transplant 2011 Oct;11(10):2132-43       171 Citations
1Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. (Cohen RT, Madadi A, Blinder MA, DeBaun MR, Strunk RC, Field JJ) Am J Hematol 2011 Sep;86(9):756-61       54 Citations
1Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. (Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Bladé J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG, International Myeloma Working Group) Leukemia 2012 Jan;26(1):149-57       650 Citations
1Transfer status: a risk factor for mortality in patients with necrotizing fasciitis. (Holena DN, Mills AM, Carr BG, Wirtalla C, Sarani B, Kim PK, Braslow BM, Kelz RR) Surgery 2011 Sep;150(3):363-70       70 Citations
1Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. (Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M) Biol Blood Marrow Transplant 2011 Dec;17(12):1869-73       29 Citations
1Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. (Dong J, Hu Z, Shu Y, Pan S, Chen W, Wang Y, Hu L, Jiang Y, Dai J, Ma H, Jin G, Shen H) Mol Carcinog 2012 Jul;51(7):546-52       48 Citations
2Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32). (Buonaccorsi JN, Kroft SH, Harrington AM, VanTuinen P, Olteanu H) Ann Diagn Pathol 2011 Dec;15(6):385-8       6 Citations
1Predictors of rehospitalization in high-utilizing patients in the VA psychiatric medical system. (Bowersox NW, Saunders SM, Berger BD) Psychiatr Q 2012 Mar;83(1):53-64       18 Citations
2Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. (Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT, Vij R, Kyle RA, Gale RP, Hari PN) Blood 2011 Aug 18;118(7):1979-88       66 Citations
1Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. (Delano MJ, Kelly-Scumpia KM, Thayer TC, Winfield RD, Scumpia PO, Cuenca AG, Harrington PB, O'Malley KA, Warner E, Gabrilovich S, Mathews CE, Laface D, Heyworth PG, Ramphal R, Strieter RM, Moldawer LL, Efron PA) J Immunol 2011 Jul 15;187(2):911-8       115 Citations
2Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. (Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole D, Hari P) Biol Blood Marrow Transplant 2011 Dec;17(12):1765-74       46 Citations
1Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. (Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV, Blood and Marrow Transplant Clinical Trials Network) Blood 2011 Jul 14;118(2):282-8       489 Citations
1Extracorporeal membrane oxygenation support for intractable primary arrhythmias and complete congenital heart block in newborns and infants: short-term and medium-term outcomes. (Dyamenahalli U, Tuzcu V, Fontenot E, Papagiannis J, Jaquiss RD, Bhutta A, Morrow WR, Erickson CC, Imamura M, Prodhan P) Pediatr Crit Care Med 2012 Jan;13(1):47-52       35 Citations
1Presenting blood pressure in traumatic brain injury: a bimodal distribution of death. (Zafar SN, Millham FH, Chang Y, Fikry K, Alam HB, King DR, Velmahos GC, de Moya MA) J Trauma 2011 Nov;71(5):1179-84       62 Citations
1Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. (Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Gale RP, Schouten HC, Spellman S, Wingard JR, Horowitz MM, Pavletic SZ) Blood 2011 Jun 16;117(24):6714-20       130 Citations
2Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70       309 Citations
1Teaching status: the impact on emergency and elective surgical care in the US. (Holena DN, Hadler R, Wirtalla C, Carr B, Morris JB, Kelz RR) Ann Surg 2011 May;253(5):1017-23       19 Citations
1Aortopulmonary window. (Barnes ME, Mitchell ME, Tweddell JS) Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011;14(1):67-74       50 Citations
1Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience. (Tsimberidou AM, Letourneau K, Wen S, Wheler J, Hong D, Naing A, Iskander NG, Uehara C, Kurzrock R) Clin Cancer Res 2011 Jun 15;17(12):4110-8       21 Citations
1Optimizing the concentration and bolus of a drug delivered by continuous infusion. (Thall PF, Szabo A, Nguyen HQ, Amlie-Lefond CM, Zaidat OO) Biometrics 2011 Dec;67(4):1638-46       13 Citations
6The effect of caudal vs intravenous morphine on early extubation and postoperative analgesic requirements for stage 2 and 3 single-ventricle palliation: a double blind randomized trial. (Stuth EA, Berens RJ, Staudt SR, Robertson FA, Scott JP, Stucke AG, Hoffman GM, Troshynski TJ, Tweddell JS, Zuperku EJ) Paediatr Anaesth 2011 Apr;21(4):441-53       21 Citations
1Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. (Lawlor MW, Read BP, Edelstein R, Yang N, Pierson CR, Stein MJ, Wermer-Colan A, Buj-Bello A, Lachey JL, Seehra JS, Beggs AH) Am J Pathol 2011 Feb;178(2):784-93       53 Citations
1Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. (Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V, Eurocord Registry, Center for International Blood and Marrow Transplant Research, New York Blood Center) Biol Blood Marrow Transplant 2011 Sep;17(9):1375-82       177 Citations
1Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice. (Semple K, Yu Y, Wang D, Anasetti C, Yu XZ) Biol Blood Marrow Transplant 2011 Mar;17(3):309-18       43 Citations
3Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? (Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC) J Clin Oncol 2011 Mar 01;29(7):805-13       172 Citations
1Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. (Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ) Arch Surg 2010 Dec;145(12):1158-63       130 Citations
1Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. (Reece DE, Vesole DH, Shrestha S, Zhang MJ, Pérez WS, Dispenzieri A, Milone GA, Abidi M, Atkins H, Bashey A, Bredeson CN, Boza WB, Freytes CO, Gale RP, Gajewski JL, Gibson J, Hale GA, Kumar S, Kyle RA, Lazarus HM, McCarthy PL, Pavlovsky S, Roy V, Weisdorf DJ, Wiernik PH, Hari PN) Clin Lymphoma Myeloma Leuk 2010 Dec;10(6):458-63       24 Citations
2Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8       258 Citations
1Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. (Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A) Mol Genet Metab 2011 Feb;102(2):111-5       62 Citations
1Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ) Int J Radiat Oncol Biol Phys 2012 Jan 01;82(1):425-34       255 Citations
1The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. (Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW) Cancer 2011 Mar 01;117(5):948-56       80 Citations
2Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. (Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, Newgard C, Slutsky A, Coimbra R, Emerson S, Minei JP, Bardarson B, Kudenchuk P, Baker A, Christenson J, Idris A, Davis D, Fabian TC, Aufderheide TP, Callaway C, Williams C, Banek J, Vaillancourt C, van Heest R, Sopko G, Hata JS, Hoyt DB, ROC Investigators) JAMA 2010 Oct 06;304(13):1455-64       234 Citations
1Take Heart America: A comprehensive, community-wide, systems-based approach to the treatment of cardiac arrest. (Lick CJ, Aufderheide TP, Niskanen RA, Steinkamp JE, Davis SP, Nygaard SD, Bemenderfer KK, Gonzales L, Kalla JA, Wald SK, Gillquist DL, Sayre MR, Osaki Holm SY, Oakes DA, Provo TA, Racht EM, Olsen JD, Yannopoulos D, Lurie KG) Crit Care Med 2011 Jan;39(1):26-33    
1Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. (Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Schwartz CL) Pediatr Hematol Oncol 2010 Nov;27(8):650-7       2 Citations
1Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine. (Kohler ME, Hallett WH, Chen QR, Khan J, Johnson BD, Orentas RJ) Cell Immunol 2010;265(1):65-73       5 Citations
1Anti-CD25 antibody (daclizumab) maintenance therapy in pancreas transplantation. (Kirchner VA, Suszynski TM, Radosevich DM, Humar A, Dunn TB, Hill MJ, Finger EB, Sutherland DE, Kandaswamy R) Transplant Proc 2010;42(6):2003-5       6 Citations
1Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. (Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM, Frangoul H, Gajewski J, Gale RP, Godder K, Hale GA, Heemskerk MB, Horan J, Kamani N, Kasow KA, Chan KW, Lee SJ, Leung WH, Lewis VA, Miklos D, Oudshoorn M, Petersdorf EW, Ringdén O, Sanders J, Schultz KR, Seber A, Setterholm M, Wall DA, Yu L, Pulsipher MA) Blood 2010 Nov 11;116(19):4007-15       106 Citations
1Implementing the 2005 American Heart Association guidelines, including use of the impedance threshold device, improves hospital discharge rate after in-hospital cardiac arrest. (Thigpen K, Davis SP, Basol R, Lange P, Jain SS, Olsen JD, Erickson BR, Schuchard TN, Aufderheide TP) Respir Care 2010 Aug;55(8):1014-9       23 Citations
1Evaluation of a modified early goal-directed therapy protocol. (Crowe CA, Mistry CD, Rzechula K, Kulstad CE) Am J Emerg Med 2010 Jul;28(6):689-93       21 Citations
1Tissue microarrays: one size does not fit all. (Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED) Diagn Pathol 2010 Jul 07;5:48       40 Citations
1Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. (Hui D, Parsons H, Nguyen L, Palla SL, Yennurajalingam S, Kurzrock R, Bruera E) Cancer 2010 Sep 15;116(18):4402-9       53 Citations
1The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. (Shaw BE, Arguello R, Garcia-Sepulveda CA, Madrigal JA) Br J Haematol 2010 Aug;150(3):251-8       87 Citations
1Graft-versus-host disease treatment: predictors of survival. (Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2010 Dec;16(12):1693-9       90 Citations
1Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. (Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ) Blood 2010 Sep 16;116(11):1839-48       170 Citations
2High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. (Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD) Bone Marrow Transplant 2011 Mar;46(3):385-92       26 Citations
1Bone marrow or peripheral blood. (Eapen M) Biol Blood Marrow Transplant 2010 Jun;16(6):868-9    
2Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6       70 Citations
1The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. (Marks DI, Wang T, Pérez WS, Antin JH, Copelan E, Gale RP, George B, Gupta V, Halter J, Khoury HJ, Klumpp TR, Lazarus HM, Lewis VA, McCarthy P, Rizzieri DA, Sabloff M, Szer J, Tallman MS, Weisdorf DJ) Blood 2010 Jul 22;116(3):366-74       168 Citations
1Knowledge translation in emergency medical services: a qualitative survey of barriers to guideline implementation. (Bigham BL, Aufderheide TP, Davis DP, Powell J, Donn S, Suffoletto B, Nafziger S, Stouffer J, Morrison LJ, ROC Investigators) Resuscitation 2010 Jul;81(7):836-40       45 Citations
1Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. (Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van Velkinburgh JC, Park LP, Glickman LT, Fowler VG Jr, Kingsmore SF, Rivers EP) Acad Emerg Med 2010 Apr;17(4):383-90       121 Citations
1Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. (Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH) J Gastrointest Surg 2010 May;14(5):849-57       47 Citations
1A microRNA expression signature for cervical cancer prognosis. (Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X) Cancer Res 2010 Feb 15;70(4):1441-8       280 Citations
1Do popular media and internet-based hospital quality ratings identify hospitals with better cardiovascular surgery outcomes? (Osborne NH, Nicholas LH, Ghaferi AA, Upchurch GR Jr, Dimick JB) J Am Coll Surg 2010 Jan;210(1):87-92       31 Citations
1Hexaminolevulinate-mediated photodynamic purging of leukemia cells from BM. (Čunderlíková B, Vasovič V, Sieber F, Furre T, Nesland JM, Peng Q) Bone Marrow Transplant 2010 Oct;45(10):1553-61       5 Citations
22010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. (Pasquini MC, Wang Z, Horowitz MM, Gale RP) Clin Transpl 2010:87-105       140 Citations
3Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ) Blood 2010 Mar 04;115(9):1850-7       201 Citations
1Limitations of the SEER database for demonstrating causal relationships between treatments and outcomes in pediatric intestinal tumors. (Lal A, Lal DR) J Surg Res 2010 Jun 15;161(2):237-9       5 Citations
2Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats. (Moralejo DH, Hansen CT, Treuting P, Hessner MJ, Fuller JM, Van Yserloo B, Jensen R, Osborne W, Kwitek AE, Lernmark A) Physiol Genomics 2010 Mar 03;41(1):9-20       9 Citations
1The association between emergency medical services staffing patterns and out-of-hospital cardiac arrest survival. (Eschmann NM, Pirrallo RG, Aufderheide TP, Lerner EB) Prehosp Emerg Care 2010;14(1):71-7       43 Citations
1Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. (Rea TD, Cook AJ, Stiell IG, Powell J, Bigham B, Callaway CW, Chugh S, Aufderheide TP, Morrison L, Terndrup TE, Beaudoin T, Wittwer L, Davis D, Idris A, Nichol G, Resuscitation Outcomes Consortium Investigators) Ann Emerg Med 2010 Mar;55(3):249-57       189 Citations
1Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. (Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D) Biol Blood Marrow Transplant 2010 Mar;16(3):421-9       32 Citations
1Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. (Migrino RQ, Mareedu RK, Eastwood D, Bowers M, Harmann L, Hari P) J Am Soc Echocardiogr 2009 Dec;22(12):1396-402       35 Citations
1A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers. (Downs-Canner S, Shaw PH) J Pediatr Hematol Oncol 2009 Dec;31(12):927-9       70 Citations
1The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. (Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ) Biol Blood Marrow Transplant 2010 Feb;16(2):253-62       26 Citations
1Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. (Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, Haut PR, Horan J, Hsu LL, Kamani N, Levine JE, Margolis D, Ohene-Frempong K, Patience M, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sullivan KM, Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease) Biol Blood Marrow Transplant 2010 Feb;16(2):263-72       167 Citations
1T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. (Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C, Yu XZ) Biol Blood Marrow Transplant 2010 Feb;16(2):170-8       95 Citations
1Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M) Biol Blood Marrow Transplant 2010 Feb;16(2):223-30       144 Citations
1No assisted ventilation cardiopulmonary resuscitation and 24-hour neurological outcomes in a porcine model of cardiac arrest. (Yannopoulos D, Matsuura T, McKnite S, Goodman N, Idris A, Tang W, Aufderheide TP, Lurie KG) Crit Care Med 2010 Jan;38(1):254-60       52 Citations
1Standardized management improves outcomes after the Norwood procedure. (Srinivasan C, Sachdeva R, Morrow WR, Gossett J, Chipman CW, Imamura M, Jaquiss RD) Congenit Heart Dis 2009;4(5):329-37       74 Citations
1Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. (Berro M, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal JA, Shaw BE) Haematologica 2010 Feb;95(2):276-83       8 Citations
1Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. (Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, Burke MJ, Blazar BR, Miller JS, McGlave PB, Weisdorf DJ, Wagner JE) Blood 2009 Nov 05;114(19):4293-9       246 Citations
2Soft-tissue sarcoma metastases identified on abdomen and pelvis CT imaging. (King DM, Hackbarth DA, Kilian CM, Carrera GF) Clin Orthop Relat Res 2009 Nov;467(11):2838-44       25 Citations
1Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. (Yuan R, Tsaih SW, Petkova SB, Marin de Evsikova C, Xing S, Marion MA, Bogue MA, Mills KD, Peters LL, Bult CJ, Rosen CJ, Sundberg JP, Harrison DE, Churchill GA, Paigen B) Aging Cell 2009 Jun;8(3):277-87       353 Citations
2Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. (Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL) Blood 2009 Sep 24;114(13):2606-16       122 Citations
2Higher hospital volume is associated with lower mortality in acute nonvariceal upper-GI hemorrhage. (Ananthakrishnan AN, McGinley EL, Saeian K) Gastrointest Endosc 2009 Sep;70(3):422-32       22 Citations
1Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? (Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF) J Gastrointest Surg 2009 Sep;13(9):1692-8       109 Citations
1Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis. (Giralt S, Vesole DH, Somlo G, Krishnan A, Stadtmauer E, Mccarthy P, Pasquini MC, Blood and Marrow Transplant Clinical Trials Network Multiple Myeloma Working Group) J Natl Cancer Inst 2009 Jul 01;101(13):964; author reply 966-7       9 Citations
2Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. (van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN) Biol Blood Marrow Transplant 2009 May;15(5):554-63       29 Citations
1Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas. (Hamadani M, Benson DM Jr, Hofmeister CC, Elder P, Blum W, Porcu P, Garzon R, Blum KA, Lin TS, Marcucci G, Devine SM) Biol Blood Marrow Transplant 2009 May;15(5):547-53       41 Citations
1Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. (Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K) Am J Gastroenterol 2009 May;104(5):1130-4       195 Citations
1Hypertension, insulin resistance, and aldosterone: sex-specific relationships. (Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA) J Clin Hypertens (Greenwich) 2009 Mar;11(3):130-7       28 Citations
1Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21       92 Citations
1Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma. (Blum KA, Hamadani M, Phillips GS, Lozanski G, Johnson AJ, Lucas DM, Smith LL, Baiocchi R, Lin TS, Porcu P, Devine SM, Byrd JC) Leuk Lymphoma 2009 Mar;50(3):349-56       6 Citations
1Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. (Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J) J Exp Med 2009 Mar 16;206(3):637-53       203 Citations
1Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. (Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2009 Apr;16(4):836-47       430 Citations
1Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience. (Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, Feng L, Kurzrock R) Cancer 2009 Mar 01;115(5):1091-9       72 Citations
2Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. (Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P) Biol Blood Marrow Transplant 2009 Jan;15(1):109-17       94 Citations
1Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. (Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J, Kim K, Kim J, Esterberg E, Juckett MB) Leuk Lymphoma 2008 Dec;49(12):2298-307       48 Citations
1Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial. (Nand S, Godwin J, Smith S, Barton K, Michaelis L, Alkan S, Veerappan R, Rychlik K, Germano E, Stiff P) Leuk Lymphoma 2008 Nov;49(11):2141-7       59 Citations
1The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. (Shaw BE) Int J Immunogenet 2008 Aug;35(4-5):367-74       11 Citations
1Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. (Ohye RG, Gaynor JW, Ghanayem NS, Goldberg CS, Laussen PC, Frommelt PC, Newburger JW, Pearson GD, Tabbutt S, Wernovsky G, Wruck LM, Atz AM, Colan SD, Jaggers J, McCrindle BW, Prakash A, Puchalski MD, Sleeper LA, Stylianou MP, Mahony L, Pediatric Heart Network Investigators) J Thorac Cardiovasc Surg 2008 Oct;136(4):968-75       120 Citations
1Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. (Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Benson DM, Blum KA, Devine SM) Leuk Lymphoma 2008 Oct;49(10):1893-8       10 Citations
2The influence of surgery in MEN-1 syndrome: observations over 150 years. (Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL, Pappas SG) Surgery 2008 Oct;144(4):695-701; discussion 701-2       16 Citations
1Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma? (Ferreri AJ, Dognini GP, Govi S, Crocchiolo R, Bouzani M, Bollinger CR, D'Incan M, Delaporte E, Hamadani M, Jardin F, Martusewicz-Boros M, Montanari M, Szomor A, Zucca E, Cavalli F, Ponzoni M) J Clin Oncol 2008 Nov 01;26(31):5134-6; author reply 5136-7       64 Citations
1Analyzing center specific outcomes in hematopoietic cell transplantation. (Logan BR, Nelson GO, Klein JP) Lifetime Data Anal 2008 Dec;14(4):389-404       16 Citations
1Regional variation in out-of-hospital cardiac arrest incidence and outcome. (Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I, Resuscitation Outcomes Consortium Investigators) JAMA 2008 Sep 24;300(12):1423-31       1668 Citations
1Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. (Kumar S, Pérez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Hari P) Biol Blood Marrow Transplant 2008 Oct;14(10):1134-1140       26 Citations
2HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-1147       64 Citations
1Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. (Alonso D, Dunn TB, Rigley T, Skorupa JY, Schriner ME, Wrenshall LE, Stevens RB) Am J Transplant 2008 Sep;8(9):1942-5       59 Citations
2Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. (Peterson AL, Deatsman S, Frommelt MA, Mussatto K, Frommelt PC) Pediatr Cardiol 2009 Feb;30(2):160-5       35 Citations
1Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia. (Advani AS, Jin T, Ramsingh G, Tiu R, Saber W, Theil K, Sobecks R, Sekeres M, Copelan E, Sungren S, Tripp B, Kalaycio M) Leuk Lymphoma 2008 Aug;49(8):1560-6       6 Citations
1Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. (Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH) Bone Marrow Transplant 2008 Dec;42(12):783-9       98 Citations
1Cytogenetically normal acute myeloid leukemia. (Saber W, Williams EC) N Engl J Med 2008 Aug 07;359(6):652; author reply 652-3       1 Citation
1No impact of NOD2/CARD15 on outcome after SCT: a reply. (Mayor NP, Shaw BE, Madrigal JA, Marsh SG) Bone Marrow Transplant 2008 Dec;42(12):837-8       2 Citations
1Inference for current leukemia free survival. (Liu L, Logan B, Klein JP) Lifetime Data Anal 2008 Dec;14(4):432-46       13 Citations
1Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3       4 Citations
1Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. (Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR) Blood 2008 Oct 01;112(7):2847-57       131 Citations
1Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. (Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P) Biol Blood Marrow Transplant 2008 Aug;14(8):904-12       51 Citations
1Association of family history with cancer recurrence and survival among patients with stage III colon cancer. (Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Schaefer P, Whittom R, Hantel A, Goldberg RM, Warren RS, Bertagnolli M, Fuchs CS) JAMA 2008 Jun 04;299(21):2515-23       74 Citations
1Impact of graft-versus-host disease on survival. (Pasquini MC) Best Pract Res Clin Haematol 2008 Jun;21(2):193-204       50 Citations
1Impact of mitral stenosis and aortic atresia on survival in hypoplastic left heart syndrome. (Glatz JA, Fedderly RT, Ghanayem NS, Tweddell JS) Ann Thorac Surg 2008 Jun;85(6):2057-62       84 Citations
1Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. (Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA) Br J Haematol 2008 Jun;142(2):318-20       7 Citations
1Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. (Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ) Biol Blood Marrow Transplant 2008 Jun;14(6):685-92       22 Citations
1Contemporary outcomes research: tools of the trade. (Calkins CM) Semin Pediatr Surg 2008 May;17(2):69-78       3 Citations
1Just, in time: ethical implications of serial predictions of death and morbidity for ventilated premature infants. (Meadow W, Lagatta J, Andrews B, Caldarelli L, Keiser A, Laporte J, Plesha-Troyke S, Subramanian M, Wong S, Hron J, Golchin N, Schreiber M) Pediatrics 2008 Apr;121(4):732-40       66 Citations
1Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. (Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA) J Clin Endocrinol Metab 2008 Jun;93(6):2173-80       165 Citations
2Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. (Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM) Med Decis Making 2008;28(2):243-53       36 Citations
1Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. (Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, Devine SM) Biol Blood Marrow Transplant 2008 Apr;14(4):480-3       35 Citations
1Magnetocardiography in the evaluation of fetuses at risk for sudden cardiac death before birth. (Cuneo BF, Strasburger JF, Wakai RT) J Electrocardiol 2008;41(2):116.e1-6       15 Citations
1Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. (Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, Woolfrey A, Kamani N) Br J Haematol 2008 Apr;141(2):216-23       48 Citations
1Bond strength of an amorphous calcium phosphate-containing orthodontic adhesive. (Foster JA, Berzins DW, Bradley TG) Angle Orthod 2008 Mar;78(2):339-44       40 Citations
1Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72       24 Citations
1Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. (Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo MS, Freytes CO, Goldstein SC, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, Schouten HC, Slavin S, Vose JM, Lazarus HM, van Besien K) Biol Blood Marrow Transplant 2008 Feb;14(2):236-45       149 Citations
1Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8       81 Citations
1Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. (Logan BR, Klein JP, Zhang MJ) Biometrics 2008 Sep;64(3):733-740       58 Citations
1Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. (Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ) J Clin Oncol 2008 Jan 10;26(2):196-203       140 Citations
1Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital. (Shaw PH, Ritchey AK) J Pediatr Hematol Oncol 2007 Dec;29(12):811-4       55 Citations
1Allogeneic hematopoietic cell transplantation for metastatic breast cancer. (Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D) Bone Marrow Transplant 2008 Mar;41(6):537-45       44 Citations
1Surgery for hilar cholangiocarcinoma: the Leeds experience. (Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP) Eur J Surg Oncol 2008 Jul;34(7):787-94       118 Citations
3Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8       163 Citations
1Importance of totally anomalous pulmonary venous connection and postoperative pulmonary vein stenosis in outcomes of heterotaxy syndrome. (Foerster SR, Gauvreau K, McElhinney DB, Geva T) Pediatr Cardiol 2008 May;29(3):536-44       56 Citations
1Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. (Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Feb;34(2):180-4       6 Citations
1Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. (Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG) BJU Int 2007 Dec;100(6):1235-9       56 Citations
1Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. (Ioachimescu AG, Brennan DM, Hoar BM, Kashyap SR, Hoogwerf BJ) Diabet Med 2007 Dec;24(12):1369-74       35 Citations
1Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. (Madrigal A, Shaw BE) Blood Cells Mol Dis 2008;40(1):40-3       13 Citations
1Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. (Hazard L, Tward JD, Szabo A, Shrieve DC) Cancer 2007 Nov 15;110(10):2191-201       72 Citations
3Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. (Tweddell JS, Ghanayem NS, Mussatto KA, Mitchell ME, Lamers LJ, Musa NL, Berger S, Litwin SB, Hoffman GM) Ann Thorac Surg 2007 Oct;84(4):1301-10; discussion 1310-1       141 Citations
1Multiple myeloma: charging toward a bright future. (Katzel JA, Hari P, Vesole DH) CA Cancer J Clin 2007;57(5):301-18       93 Citations
1Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. (Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, Maltsev N, Zahrt TC, Frank DW) Infect Immun 2007 Nov;75(11):5376-89       75 Citations
1Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. (Atallah E, Cortes J, O'Brien S, Pierce S, Rios MB, Estey E, Markman M, Keating M, Freireich EJ, Kantarjian H) Blood 2007 Nov 15;110(10):3547-51       73 Citations
1A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. (Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG) Int J Gynecol Cancer 2008;18(3):400-6       37 Citations
1Mapping MHC-resident transplantation determinants. (Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW, International Histocompatibility Working Group in Transplantation) Biol Blood Marrow Transplant 2007 Aug;13(8):986-95       16 Citations
1Shear bond strength comparison between two orthodontic adhesives and self-ligating and conventional brackets. (Northrup RG, Berzins DW, Bradley TG, Schuckit W) Angle Orthod 2007 Jul;77(4):701-6       41 Citations
1Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. (Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, Prasad KR) Br J Surg 2007 Nov;94(11):1395-402       118 Citations
1Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. (Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED) Cancer 2007 Aug 15;110(4):783-90       64 Citations
1Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. (Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A) N Engl J Med 2007 May 31;356(22):2282-92       303 Citations
1Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. (Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH) Cancer 2007 Jul 01;110(1):47-55       241 Citations
1Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab. (Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL) Biol Blood Marrow Transplant 2007 Jun;13(6):724-33       11 Citations
1The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. (Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH) Biol Blood Marrow Transplant 2007 May;13(5):550-9       25 Citations
2The double patch repair for complete atrioventricularis communis. (Litwin SB, Tweddell JS, Mitchell ME, Mussatto KA) Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2007:21-7       22 Citations
1Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. (Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ) Blood 2007 Jul 01;110(1):409-17       68 Citations
1Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. (Malik HZ, Gomez D, Wong V, Al-Mukthar A, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2007 Oct;33(8):1003-9       64 Citations
1Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. (Bishton MJ, Lush RJ, Byrne JL, Russell NH, Shaw BE, Haynes AP) Br J Haematol 2007 Mar;136(5):752-61       22 Citations
1Induction of natural killer cell responses by ectromelia virus controls infection. (Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM) J Virol 2007 Apr;81(8):4070-9       93 Citations
3Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. (Gilligan MA, Neuner J, Zhang X, Sparapani R, Laud PW, Nattinger AB) Am J Public Health 2007 Mar;97(3):539-44       52 Citations
2Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5       157 Citations
1Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH, Li D) Cancer 2007 Mar 01;109(5):840-8       48 Citations
1A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome. (Fenaux P, Raza A, Mufti GJ, Aul C, Germing U, Kantarjian H, Cripe L, Kerstens R, De Porre P, Kurzrock R) Blood 2007 May 15;109(10):4158-63       104 Citations
1Fetal intervention for mass lesions and hydrops improves outcome: a 15-year experience. (Grethel EJ, Wagner AJ, Clifton MS, Cortes RA, Farmer DL, Harrison MR, Nobuhara KK, Lee H) J Pediatr Surg 2007 Jan;42(1):117-23       121 Citations
1Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. (Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS) BMC Cardiovasc Disord 2006 Dec 15;6:48       136 Citations
1Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. (Bartz PJ, Driscoll DJ, Dearani JA, Puga FJ, Danielson GK, O'Leary PW, Earing MG, Warnes CA, Hodge DO, Cetta F) J Am Coll Cardiol 2006 Dec 05;48(11):2301-5       143 Citations
1Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis. (Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC) Cancer 2006 Nov 15;107(10):2392-400       58 Citations
6Early cavopulmonary anastomosis after Norwood procedure results in excellent Fontan outcome. (Jaquiss RD, Siehr SL, Ghanayem NS, Hoffman GM, Fedderly RT, Cava JR, Mussatto KA, Tweddell JS) Ann Thorac Surg 2006 Oct;82(4):1260-5; discussion 1265-6       41 Citations
1Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. (Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL) Biol Blood Marrow Transplant 2006 Jul;12(7):758-69       107 Citations
1Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. (Kahl BS, Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH, Wisconsin Oncology Network) Ann Oncol 2006 Sep;17(9):1418-23       98 Citations
1Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? (Wong SJ, Machtay M, Li Y) J Clin Oncol 2006 Jun 10;24(17):2653-8       117 Citations
2Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). (Firat S, Pleister A, Byhardt RW, Gore E) Am J Clin Oncol 2006 Jun;29(3):252-7       48 Citations
1Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. (Tsimberidou AM, Keating MJ, Bueso-Ramos CE, Kurzrock R) Leuk Lymphoma 2006 May;47(5):827-36       39 Citations
1Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. (Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND) World J Surg 2006 May;30(5):643-53       128 Citations
2Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. (Navarro WH, Loberiza FR Jr, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, Rizzo JD) Biol Blood Marrow Transplant 2006 May;12(5):541-51       83 Citations
1Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. (Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS) Breast Cancer Res 2006;8(2):R23       167 Citations
1A comparison of bond strength between direct- and indirect-bonding methods. (Linn BJ, Berzins DW, Dhuru VB, Bradley TG) Angle Orthod 2006 Mar;76(2):289-94       40 Citations
1Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation. (Johnson GK, Saeian K, Geenen JE) Curr Gastroenterol Rep 2006 Apr;8(2):147-55       27 Citations
1Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. (Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2006 Apr;13(4):582-94       132 Citations
1Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. (Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM) Br J Haematol 2006 Mar;132(6):755-69       56 Citations
1Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. (Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D) J Clin Oncol 2006 Feb 01;24(4):663-7       93 Citations
1Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. (Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP) Neuro Oncol 2006 Jan;8(1):47-52       58 Citations
1Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) JAMA 2006 Jan 25;295(4):389-97       114 Citations
3Chemoembolization in patients at high risk: results and complications. (Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA) J Vasc Interv Radiol 2006 Jan;17(1):47-53       50 Citations
2Resistance to fracture of two all-ceramic crown materials following endodontic access. (Wood KC, Berzins DW, Luo Q, Thompson GA, Toth JM, Nagy WW) J Prosthet Dent 2006 Jan;95(1):33-41       50 Citations
1The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. (Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA, Pagliuca A, Mufti GJ, Byrne JL) Haematologica 2005 Nov;90(11):1562-9       22 Citations
1Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. (Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP) Cancer 2005 Nov 01;104(9):1948-55       113 Citations
1Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. (Duarte RF, Delgado J, Shaw BE, Wrench DJ, Ethell M, Patch D, Dhillon AP, Mackinnon S, Potter MN, Quaglia AF) Biol Blood Marrow Transplant 2005 Oct;11(10):805-13       40 Citations
2BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. (Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP) Kidney Int 2005 Oct;68(4):1834-9       224 Citations
1A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma. (Morgan-Meadows S, Mulkerin D, Berlin JD, Kim K, Bailey H, Saphner T, Jumonville A, Hansen R, Ahuja H, McFarland T, Thomas JP) Oncology 2005;69(2):130-4       16 Citations
1Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. (Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A) Proc Natl Acad Sci U S A 2005 Aug 09;102(32):11563-8       134 Citations
1Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea. (Sakhuja R, Chen AA, Anwaruddin S, Baggish AL, Januzzi JL Jr) Am J Cardiol 2005 Jul 15;96(2):263-6       11 Citations
1Effect of an inspiratory impedance threshold device on hemodynamics during conventional manual cardiopulmonary resuscitation. (Pirrallo RG, Aufderheide TP, Provo TA, Lurie KG) Resuscitation 2005 Jul;66(1):13-20       79 Citations
1Pairwise multiple comparison adjustment in survival analysis. (Logan BR, Wang H, Zhang MJ) Stat Med 2005 Aug 30;24(16):2509-23       22 Citations
1Detection and prevention of neurologic injury in the intensive care unit. (Hoffman GM) Cardiol Young 2005 Feb;15 Suppl 1:149-53       17 Citations
1Challenges facing the child, adolescent, and young adult after the arterial switch operation. (Mussatto K, Wernovsky G) Cardiol Young 2005 Feb;15 Suppl 1:111-21       24 Citations
1Results of multimodal treatment for desmoplastic small round cell tumors. (Lal DR, Su WT, Wolden SL, Loh KC, Modak S, La Quaglia MP) J Pediatr Surg 2005 Jan;40(1):251-5       255 Citations
1Neuroendocrine hepatic metastases: does aggressive management improve survival? (Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA) Ann Surg 2005 May;241(5):776-83; discussion 783-5       311 Citations
1MELD score does not discriminate against patients with hepatic encephalopathy. (Bajaj JS, Saeian K) Dig Dis Sci 2005 Apr;50(4):753-6       15 Citations
1Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6       24 Citations
1Clinical evaluation of an inspiratory impedance threshold device during standard cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. (Aufderheide TP, Pirrallo RG, Provo TA, Lurie KG) Crit Care Med 2005 Apr;33(4):734-40       116 Citations
1Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):444-9       30 Citations
1Optimizing outcomes and bridging biliary atresia into adulthood. (Sokol RJ, Mack CL) Hepatology 2005 Feb;41(2):231-3       14 Citations
1Pancreaticoduodenectomy with vascular resection: margin status and survival duration. (Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB) J Gastrointest Surg 2004 Dec;8(8):935-49; discussion 949-50       517 Citations
1Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 01;22(23):4762-71       530 Citations
2Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75       971 Citations
1Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation? (Gore E, Choy H) Semin Radiat Oncol 2004 Oct;14(4):292-7       13 Citations
1Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. (Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS) Cancer 2005 Jan 01;103(1):85-91       83 Citations
1Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. (Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr) Int J Radiat Oncol Biol Phys 2004 Nov 01;60(3):853-60       478 Citations
1Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix       55 Citations
1Racial variations in processes of care for patients with community-acquired pneumonia. (Mortensen EM, Cornell J, Whittle J) BMC Health Serv Res 2004 Aug 10;4(1):20       23 Citations
2Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry) Blood 2004 Dec 01;104(12):3797-803       107 Citations
1Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. (Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E) J Clin Oncol 2004 Jul 15;22(14):2856-64       168 Citations
1Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. (Barber FD, Mavligit G, Kurzrock R) Cancer Treat Rev 2004 Aug;30(5):425-36       39 Citations
1Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group. (Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB 3rd) Oncology 2004;66(4):303-9       34 Citations
1Factors influencing survival in newborns with congenital diaphragmatic hernia: the relative role of timing of surgery. (Rozmiarek AJ, Qureshi FG, Cassidy L, Ford HR, Hackam DJ) J Pediatr Surg 2004 Jun;39(6):821-4; discussion 821-4       67 Citations
1Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. (Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I) J Clin Oncol 2004 Jun 01;22(11):2167-71       210 Citations
1Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. (Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA, Chronic Leukemia Study Writing Committee of the International Bone Marrow Transplant Registry) Br J Haematol 2004 Jun;125(5):613-20       82 Citations
2Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group 9501/Intergroup) N Engl J Med 2004 May 06;350(19):1937-44       2803 Citations
1Hyperventilation-induced hypotension during cardiopulmonary resuscitation. (Aufderheide TP, Sigurdsson G, Pirrallo RG, Yannopoulos D, McKnite S, von Briesen C, Sparks CW, Conrad CJ, Provo TA, Lurie KG) Circulation 2004 Apr 27;109(16):1960-5       714 Citations
1Gastric carcinoma. (Phan AT, Ajani JA) Curr Oncol Rep 2004 May;6(3):192-8       9 Citations
2A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM) Blood 2004 Jul 15;104(2):579-85       612 Citations
1A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. (Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A, Neonatal Inhaled Nitric Oxide Study Group) Pediatrics 2004 Mar;113(3 Pt 1):559-64       163 Citations
1Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. (Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM) Cancer 2004 Mar 01;100(5):942-9       48 Citations
1Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. (Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ) Am J Clin Oncol 2004 Feb;27(1):51-6       94 Citations
1Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies. (Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock R) Cancer 2004 Feb 01;100(3):574-80       22 Citations
1Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease. (Davis ID, Ho M, Hupertz V, Avner ED) Pediatr Transplant 2003 Oct;7(5):364-9       59 Citations
1A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa. (McCoy AG, Smith EP, Atkinson ME, Baranski B, Kahl BS, Juckett M, Mitchell T, Gangnon R, Longo WL) Bone Marrow Transplant 2004 Jan;33(1):19-24       6 Citations
1Prehospital hyperventilation after brain injury: a prospective analysis of prehospital and early hospital hyperventilation of the brain-injured patient. (Lal D, Weiland S, Newton M, Flaten A, Schurr M) Prehosp Disaster Med 2003;18(1):20-3    
2Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB) Surgery 2003 Dec;134(6):890-9; discussion 899-901       74 Citations
6Home surveillance program prevents interstage mortality after the Norwood procedure. (Ghanayem NS, Hoffman GM, Mussatto KA, Cava JR, Frommelt PC, Rudd NA, Steltzer MM, Bevandic SM, Frisbee SS, Jaquiss RD, Litwin SB, Tweddell JS) J Thorac Cardiovasc Surg 2003 Nov;126(5):1367-77       332 Citations
1Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver (Br J Surg 2003; 90: 963-969). (Rahman S, Toogood GJ, Lodge PJ, Prasad KR) Br J Surg 2003 Nov;90(11):1453       4 Citations
1Redo infrainguinal bypass: factors predicting patency and limb salvage. (Rossi PJ, Skelly CL, Meyerson SL, Bassiouny HS, Katz D, Schwartz LB, McKinsey JF, Gewertz BL, Desai TR) Ann Vasc Surg 2003 Sep;17(5):492-502       25 Citations
1Minimally invasive mitral valve repair suggests earlier operations for mitral valve disease. (Greelish JP, Cohn LH, Leacche M, Mitchell M, Karavas A, Fox J, Byrne JG, Aranki SF, Couper GS) J Thorac Cardiovasc Surg 2003 Aug;126(2):365-71; discussion 371-3       68 Citations
2High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. (Firat S, Murray K, Erickson B) Int J Radiat Oncol Biol Phys 2003 Sep 01;57(1):201-7       40 Citations
3Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. (van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora AL, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM) Blood 2003 Nov 15;102(10):3521-9       326 Citations
1Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer. (Gore EM) Oncology (Williston Park) 2003 Jun;17(6):775-9; discussion 779-80, 784, 787 passim       10 Citations
2Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. (Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH) Bone Marrow Transplant 2003 Jul;32(2):151-5       4 Citations
1Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. (Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R) J Am Acad Dermatol 2003 Jul;49(1):35-49       67 Citations
1Optimistic expectations and survival after hematopoietic stem cell transplantation. (Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC) Biol Blood Marrow Transplant 2003 Jun;9(6):389-96       52 Citations
1Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. (Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB) Blood 2003 Aug 01;102(3):802-9       125 Citations
2Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. (Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N) Br J Haematol 2003 Mar;120(5):793-800       148 Citations
2Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. (Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL) Arch Pathol Lab Med 2003 Feb;127(2):208-12       75 Citations
1The injured child is resistant to multiple organ failure: a different inflammatory response? (Calkins CM, Bensard DD, Moore EE, McIntyre RC, Silliman CC, Biffl W, Harken AH, Partrick DA, Offner PJ) J Trauma 2002 Dec;53(6):1058-63       69 Citations
1Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. (Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL) Ann Oncol 2002 Nov;13(11):1819-25       8 Citations
3Improved survival in resected biliary malignancies. (Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, Wilson SD, Demeure MJ, Rilling WS, Dua KS, Pitt HA) Surgery 2002 Oct;132(4):555-63; discission 563-4       175 Citations
1Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. (Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, Kampalath B, Cleveland RP) Blood 2002 Dec 15;100(13):4671-5       55 Citations
4Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. (Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB) Circulation 2002 Sep 24;106(12 Suppl 1):I82-9       512 Citations
2Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 01;54(2):357-64       190 Citations
1Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. (Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR) Head Neck 2002 Sep;24(9):841-9       104 Citations
2Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM) Blood 2002 Sep 15;100(6):1997-2004       254 Citations
1Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. (Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd) J Clin Oncol 2002 Aug 01;20(15):3270-5       723 Citations
1Clinical importance of HIV and depressive symptoms among veterans with HIV infection. (Kilbourne AM, Justice AC, Rollman BL, McGinnis KA, Rabeneck L, Weissman S, Smola S, Schultz R, Whittle J, Rodriguez-Barradas M) J Gen Intern Med 2002 Jul;17(7):512-20       117 Citations
1Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. (Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM) Blood 2002 Jul 15;100(2):406-14       470 Citations
2Autologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80       15 Citations
1Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. (Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB) J Gerontol A Biol Sci Med Sci 2002 Jun;57(6):M401-6       18 Citations
1Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. (Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Cairo M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza F, Kollman C, Horowitz M) Biol Blood Marrow Transplant 2002;8(4):213-20       49 Citations
1Survival of women after breast conserving surgery for early stage breast cancer. (Du Xianglin, Freeman JL, Nattinger AB, Goodwin JS) Breast Cancer Res Treat 2002 Mar;72(1):23-31       33 Citations
2Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57       176 Citations
2Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. (Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ) J Clin Oncol 2002 Apr 15;20(8):2118-26       190 Citations
1Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA) Int J Radiat Oncol Biol Phys 2002 Apr 01;52(5):1293-302       202 Citations
1Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. (Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J) J Clin Oncol 2002 Apr 01;20(7):1832-7       120 Citations
1Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. (Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB) Int J Radiat Oncol Biol Phys 2002 Feb 01;52(2):333-8       185 Citations
1A new method for estimating probability of survival in pediatric patients using revised TRISS methodology based on age-adjusted weights. (Schall LC, Potoka DA, Ford HR) J Trauma 2002 Feb;52(2):235-41       40 Citations
2Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. (Drobyski WR, Klein J, Flomenberg N, Pietryga D, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 2002 Feb 01;99(3):806-14       87 Citations
3Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30       58 Citations
1Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. (Klein JP, Rizzo JD, Zhang MJ, Keiding N) Bone Marrow Transplant 2001 Nov;28(10):909-15       211 Citations
1Natural history of claudication: long-term serial follow-up study of 1244 claudicants. (Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley ME, Muluk SC) J Vasc Surg 2001 Dec;34(6):962-70       135 Citations
1Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. (Fasseas P, Cohen M, Kopistansky C, Bowers B, McCormick DJ, Kasper K, Christenson JT, Parris TM, Miller MF) J Invasive Cardiol 2001 Oct;13(10):679-83       25 Citations
1Improved functional outcome for severely injured children treated at pediatric trauma centers. (Potoka DA, Schall LC, Ford HR) J Trauma 2001 Nov;51(5):824-32; discussion 832-4       154 Citations
1The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM) Exp Hematol 2001 Nov;29(11):1336-46    
1Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18       74 Citations
1Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. (Bresnahan BA, McBride MA, Cherikh WS, Hariharan S) Transplantation 2001 Jul 27;72(2):256-61       120 Citations
1Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. (Sileri P, Schena S, Morini S, Rastellini C, Pham S, Benedetti E, Cicalese L) Transplantation 2001 Jul 15;72(1):27-30       51 Citations
1High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, Strottmann J, Pulmano C, Mohiuddin M) J Clin Oncol 2001 Jul 15;19(14):3333-9       31 Citations
1Oral hypoglycemic agents in coronary artery bypass grafting. (Almassi GH, Warltier D) Ann Thorac Surg 2001 Jun;71(6):2086    
2Transplant registries: guiding clinical decisions and improving outcomes. (Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML) Oncology (Williston Park) 2001 May;15(5):649-59; discussion 663-4, 666       30 Citations
1Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001;5(1):2-5       19 Citations
1Statistical methods in cancer research. (Simpson PM, Spratt JA, Spratt JS) J Surg Oncol 2001 Mar;76(3):201-23       5 Citations
1Role of CFTR in autosomal recessive polycystic kidney disease. (Nakanishi K, Sweeney WE Jr, Macrae Dell K, Cotton CU, Avner ED) J Am Soc Nephrol 2001 Apr;12(4):719-725       36 Citations
1Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32       329 Citations
1Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM, Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee) J Clin Oncol 2001 Jan 15;19(2):406-13       197 Citations
1The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme. (Gamburg ES, Regine WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB) Int J Radiat Oncol Biol Phys 2000 Dec 01;48(5):1359-62       37 Citations
1Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727       8 Citations
1Clinical significance of microsatellite instability in endometrial carcinoma. (Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ) Cancer 2000 Oct 15;89(8):1758-64       113 Citations
1Radical hysterectomy for cervical cancer in obese women. (Cohn DE, Swisher EM, Herzog TJ, Rader JS, Mutch DG) Obstet Gynecol 2000 Nov;96(5 Pt 1):727-31       20 Citations
1p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. (Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ) Surgery 2000 Oct;128(4):520-30       30 Citations
1Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. (Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E) N Engl J Med 2000 Jun 22;342(25):1846-54       777 Citations
2Improved graft survival after renal transplantation in the United States, 1988 to 1996. (Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D) N Engl J Med 2000 Mar 02;342(9):605-12       1699 Citations
1Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. (Porter DL, Collins RH Jr, Hardy C, Kernan NA, Drobyski WR, Giralt S, Flowers ME, Casper J, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin JH) Blood 2000 Feb 15;95(4):1214-21       164 Citations
1Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM) J Clin Oncol 2000 Jan;18(2):340-7       213 Citations
1Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. (Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM) Blood 2000 Jan 15;95(2):410-5       28 Citations
1Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11       91 Citations
1Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43       67 Citations
1Cryotherapy extends the indications for treatment of colorectal liver metastases. (Wallace JR, Christians KK, Pitt HA, Quebbeman EJ) Surgery 1999 Oct;126(4):766-72; discussion 772-4       59 Citations
1Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). (Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V) Transplantation 1999 Sep 15;68(5):635-41       226 Citations
1Stroke in cardiac surgical patients: determinants and outcome. (Almassi GH, Sommers T, Moritz TE, Shroyer AL, London MJ, Henderson WG, Sethi GK, Grover FL, Hammermeister KE) Ann Thorac Surg 1999 Aug;68(2):391-7; discussion 397-8       130 Citations
3T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. (Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 1999 Jul 15;94(2):434-41       78 Citations
1The outcome of artificial urinary sphincter placement after a mean 15-year follow-up in a paediatric population. (Kryger JV, Spencer Barthold J, Fleming P, González R) BJU Int 1999 Jun;83(9):1026-31       60 Citations
1Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. (Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML, Luzzatto L, Horowitz MM, Gordon-Smith EC) Br J Haematol 1999 Feb;104(2):392-6       115 Citations
1Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation. (Dunn TB, Asolati M, Holman DM, Raofi V, Jovanovic B, Pollak R, Benedetti E) Surgery 1999 Feb;125(2):155-9       30 Citations
1Skin breakdown in children and high-frequency oscillatory ventilation. (Schmidt JE, Berens RJ, Zollo MB, Weisner M, Weigle CG) Arch Phys Med Rehabil 1998 Dec;79(12):1565-9       13 Citations
1Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50       229 Citations
1Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. (Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA) Med Pediatr Oncol 1998 Dec;31(6):483-90       20 Citations
1Cytokine deregulation in hematological malignancies: clinical and biological implications. (Kurzrock R) Clin Cancer Res 1997 Dec;3(12 Pt 2):2581-4       44 Citations
1Prognostic value of intraoperative blood flow measurements in vascular access surgery. (Johnson CP, Zhu YR, Matt C, Pelz C, Roza AM, Adams MB) Surgery 1998 Oct;124(4):729-37; discussion 737-8       53 Citations
1Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. (Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR) Blood 1998 Oct 01;92(7):2303-14       520 Citations
2Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. (Drobyski WR, Pelz C, Kabler-Babbitt C, Hessner M, Baxter-Lowe LA, Keever-Taylor CA) Biol Blood Marrow Transplant 1998;4(1):3-12       7 Citations
1Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. (Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R) Blood 1998 Aug 15;92(4):1150-9       303 Citations
1Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. (Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Br J Surg 1998 May;85(5):611-7       298 Citations
1Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40       162 Citations
1Children's ability to delay gratification: longitudinal relations to mother-child attachment. (Jacobsen T, Huss M, Fendrich M, Kruesi MJ, Ziegenhain U) J Genet Psychol 1997 Dec;158(4):411-26       73 Citations
1Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. (McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA) Am J Surg 1997 Dec;174(6):605-8; discussion 608-9       205 Citations
1Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. (Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM) Br J Haematol 1997 Oct;99(1):23-9       6 Citations
1Topotecan in platinum- and paclitaxel-resistant ovarian cancer. (Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ) Gynecol Oncol 1997 Sep;66(3):480-6       147 Citations
1The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia. (Talpaz M, Kantarjian HM, O'Brien S, Kurzrock R) Baillieres Clin Haematol 1997 Jun;10(2):291-305       13 Citations
1IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. (Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM) Br J Haematol 1997 Jun;97(4):855-64       594 Citations
1Second cancer risk in hairy cell leukemia: analysis of 350 patients. (Kurzrock R, Strom SS, Estey E, O'Brien S, Keating MJ, Jiang H, Adams T, Talpaz M) J Clin Oncol 1997 May;15(5):1803-10       110 Citations
1Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB) J Clin Oncol 1997 Mar;15(3):928-37       508 Citations
1Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. (Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J) J Clin Oncol 1997 Feb;15(2):433-44       1141 Citations
1bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. (Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL) Clin Cancer Res 1996 Dec;2(12):2015-22       56 Citations
1Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. (Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J) Br J Haematol 1996 Jul;94(1):65-72       88 Citations
1Mortality and neurologic morbidity after repair of traumatic aortic disruption. (Nocolosi AC, Almassi GH, Bousamra M 2nd, Haasler GB, Olinger GN) Ann Thorac Surg 1996 Mar;61(3):875-8       31 Citations
1Circadian variation in sudden cardiac death: effects of age, sex, and initial cardiac rhythm. (Thakur RK, Hoffmann RG, Olson DW, Joshi R, Tresch DD, Aufderheide TP, Ip JH) Ann Emerg Med 1996 Jan;27(1):29-34       50 Citations
1Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction. (Wasilewski SJ, Ferrick KJ, Roth JA, Kim SG, Fisher JD) Am J Cardiol 1995 Dec 15;76(17):1247-52       1 Citation
1Does an additional source of pulmonary blood flow alter outcome after a bidirectional cavopulmonary shunt? (Frommelt MA, Frommelt PC, Berger S, Pelech AN, Lewis DA, Tweddell JS, Litwin SB) Circulation 1995 Nov 01;92(9 Suppl):II240-4       84 Citations
1Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. (Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R) Blood 1995 May 01;85(9):2516-20       56 Citations
1Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. (Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M) Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):743-51       15 Citations
1Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. (Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB, Williams RD) J Urol 1994 Dec;152(6 Pt 2):2272-5       38 Citations
1Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. (Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink MP, Talpaz M) Blood 1994 Nov 01;84(9):3142-7       60 Citations
1Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. (Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW) Blood 1994 Oct 01;84(7):2363-73       41 Citations
1Identical-twin bone marrow transplants for leukemia. (Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM) Ann Intern Med 1994 Apr 15;120(8):646-52       256 Citations
1Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). (Holland NR, Power C, Mathews VP, Glass JD, Forman M, McArthur JC) Neurology 1994 Mar;44(3 Pt 1):507-14       152 Citations
1Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1994:87-98       4 Citations
1Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience). (Kim SG, Maloney JD, Pinski SL, Choue CW, Ferrick KJ, Roth JA, Gross J, Brodman R, Furman S, Fisher JD) Am J Cardiol 1993 Dec 01;72(17):1263-7       34 Citations
1Nonfunctioning islet cell carcinoma of the pancreas. (Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC) Surgery 1993 Dec;114(6):1175-81; discussion 1181-2       104 Citations
1Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. (Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A) Blood 1993 Oct 01;82(7):2235-8       191 Citations
1Outcome after allogeneic bone marrow transplant for leukemia in older adults. (Ringdén O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM) JAMA 1993 Jul 07;270(1):57-60       130 Citations
1Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. (Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M) Cancer Res 1993 May 01;53(9):2118-22       163 Citations
1Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. (Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, Cox JD) J Clin Oncol 1993 Feb;11(2):233-8       68 Citations
1Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry. (Horowitz MM, Bortin MM) Am J Pediatr Hematol Oncol 1993 Feb;15(1):56-64       19 Citations
1Second HLA-identical sibling transplants for leukemia recurrence. (Mrsíc M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP, Herzig RH, Prentice HG) Bone Marrow Transplant 1992 Apr;9(4):269-75       164 Citations
1Prehospital bicarbonate use in cardiac arrest: a 3-year experience. (Aufderheide TP, Martin DR, Olson DW, Aprahamian C, Woo JW, Hendley GE, Hargarten KM, Thompson B) Am J Emerg Med 1992 Jan;10(1):4-7       58 Citations
1Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. (Lundberg JH, Hansen RM, Chitambar CR, Lawton CA, Gottlieb M, Anderson T, Ash RC) J Clin Oncol 1991 Oct;9(10):1848-59       34 Citations
1Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. (Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G) Ann Intern Med 1991 Jul 01;115(1):13-8       143 Citations
1DNA content in nasopharyngeal carcinoma. (Cheng DS, Campbell BH, Clowry LJ, Hopwood LE, Murray KJ, Toohill RJ, Hoffmann RG) Am J Otolaryngol 1990;11(6):393-7       9 Citations
1Comparison of outcome of paramedic-witnessed cardiac arrest in patients younger and older than 70 years. (Tresch DD, Thakur RK, Hoffmann RG, Aufderheide TP, Brooks HL) Am J Cardiol 1990 Feb 15;65(7):453-7       55 Citations